Jul 15, 9:00 AMRoboStrategy, Inc. announces completion of approximately $16 million in private share issuances, including a $10 million investment by CEO Andrew Kang.

Index	-
Market Cap	587.95M
Enterprise Value	-
Income	-
Sales	-
Book/sh	-
Cash/sh	-
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	May 11, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	-
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-10.79%
SMA50	-7.93%
SMA200	-7.93%
Trades

Shs Outstand	20.27M
Shs Float	-
Short Float	-
Short Ratio	1.71
Short Interest	1.39M
52W High	59.00 -50.85%
52W Low	19.20 51.04%
Volatility	11.29% 15.18%
ATR (14)	5.03
RSI (14)	43.43
Beta	-
Rel Volume	0.14
Avg Volume	812.47K
Volume	5,734

Perf Week	-11.93%
Perf Month	-10.71%
Perf Quarter	-
Perf Half Y	-
Perf YTD	-50.85%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	29.25
Price	29.00
Change	-0.85%

Jul-15-26 08:56AM	RoboStrategy, Inc. Raises Approximately $16.0 Million Through Private Share Issuances, Including $10.0 Million Investment by CEO Andrew Kang (GlobeNewswire) -13.95%
Jul-08-26 08:30AM	RoboStrategy, Inc. Announces Updated Net Asset Value and Additional Private Placements (GlobeNewswire)
Jun-29-26 08:40AM	RoboStrategy, Inc. Raises Approximately $33.9 Million Through Private Share Issuances (GlobeNewswire) +6.19%
Jun-26-26 09:00AM	RoboStrategy, Inc. Raises Approximately $36.5 Million Through Private Share Issuances (GlobeNewswire) +10.35%
Jun-24-26 09:20AM	RoboStrategy, Inc. Updates Net Asset Value as of June 22, 2026 (GlobeNewswire) -11.61%
08:00AM	Loading…
Jun-18-26 08:00AM	RoboStrategy, Inc. Raises Approximately $28.9 Million Through Private Share Issuances (GlobeNewswire)
Jun-11-26 08:00AM	GiantLeap Capital Announces Strategic Investment in Standard Bots, America's Largest Manufacturer of AI-Native Industrial Robots (PR Newswire) -6.95%
Jun-04-26 10:01AM	RoboStrategy, Inc. to Host Virtual Investor Presentation on June 10, 2026 (GlobeNewswire) +15.67%
Jun-03-26 05:42AM	RoboStrategy CEO Explains Why He Shifted Focus From Crypto To Physical AI Calls RoboStrategy The MicroStrategy Of Robotics (Stocktwits) +14.39%
May-20-26 09:00AM	RoboStrategy Announces Andrew Kang as Chief Executive Officer (GlobeNewswire) +16.65%
May-15-26 08:30AM	RoboStrategy, Inc. Enters Into Committed Equity Facility of up to $2 Billion from Roth Principal Investments, LLC to Support Strategic Growth Initiatives (GlobeNewswire) +32.88%
May-11-26 07:00AM	RoboStrategy, Inc. Lists on NASDAQ Under Ticker "BOT", Enabling Investors to Access a Portfolio of Robotics and Physical AI Companies in a Single Stock (GlobeNewswire)

RoboStrategy, Inc. is a non-diversified, closed-end management investment company, which engages in investing in equity and equity-linked securities of private and public companies operating in the fields of robotics and embodied artificial intelligence. The company was founded on May 23, 2025 and is headquartered in San Juan, Puerto Rico.

PresidentMr. Andrew Kang

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kang Andrew Kai	President	Jul 14 '26	Buy	36.71	272,405	9,999,988	2,027,687	Jul 15 05:12 PM

COE 51 Talk Online Education Group ADR daily Stock Chart

Peers: GOTU LGCY FC EDU APEI LINC LAUR LRN PRDO LOPE

Index	-
Market Cap	69.48M
Enterprise Value	36.94M
Income	-16.63M
Sales	108.88M
Book/sh	-5.61
Cash/sh	8.34
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	729
IPO	Jun 10, 2016

P/E	-
Forward P/E	-
PEG	-
P/S	0.64
P/B	-
P/C	1.96
P/FCF	-
EV/EBITDA	-
EV/Sales	0.34
Quick Ratio	0.62
Current Ratio	0.62
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-2.80
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	27.91% -
Sales past 3/5Y	85.45% -20.27%
EPS Y/Y TTM	-243.73%
Sales Y/Y TTM	82.80%
EPS Q/Q	-54.30%
Sales Q/Q	71.19%
Earnings	Jun 12 BMO
EPS/Sales Surpr.	- -

Insider Own	11.09%
Insider Trans	-
Inst Own	6.54%
Inst Trans	-3.28%
ROA	-30.02%
ROE	-
ROIC	-
Gross Margin	73.39%
Oper. Margin	-12.43%
Profit Margin	-15.28%
SMA20	2.18%
SMA50	-22.97%
SMA200	-45.70%
Trades

Shs Outstand	4.26M
Shs Float	3.79M
Short Float	0.49%
Short Ratio	1.63
Short Interest	0.02M
52W High	56.13 -70.94%
52W Low	14.66 11.26%
Volatility	6.03% 9.26%
ATR (14)	1.41
RSI (14)	37.33
Beta	0.82
Rel Volume	0.00
Avg Volume	11.40K
Volume	0

Perf Week	-2.34%
Perf Month	-16.98%
Perf Quarter	-37.27%
Perf Half Y	-42.18%
Perf YTD	-48.92%
Perf Year	-43.80%
Perf 3Y	100.62%
Perf 5Y	-41.58%
Perf 10Y	-79.61%
Recom	1.00
Target Price	55.88
Prev Close	16.31
Price	16.31
Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-21	Downgrade	The Benchmark Company	Buy → Hold
Jul-22-21	Reiterated	Needham	Buy	$36 → $32
Mar-10-20	Initiated	Needham	Buy	$36
Jan-10-20	Initiated	The Benchmark Company	Buy	$14

Jul-07-26 08:00PM	51Talk Marks 15th Anniversary with Global Curriculum Upgrade to Enhance Children's English Communication Skills (PR Newswire)
Jun-12-26 03:00PM	51 Talk Online Education Group (COE) Q1 2026 Earnings Call Highlights: Surging Revenues Amid ... (GuruFocus.com) -8.45%
07:00AM	51Talk Online Education Group Announces First Quarter 2026 Results (PR Newswire)
Jun-10-26 06:00AM	51Talk Online Education Group to Report First Quarter 2026 Financial Results on Friday, June 12, 2026 (PR Newswire)
Apr-23-26 08:15AM	51Talk Online Education Group Files Annual Report on Form 20-F for Fiscal Year of 2025 (PR Newswire) +11.59%
07:35AM	Loading…
Mar-27-26 07:35AM	51Talk Online Education Group Announces the Results for the Fourth Quarter and Full Year 2025 (PR Newswire)
Mar-25-26 07:20AM	51Talk Online Education Group to Report Fourth Quarter and Full Year 2025 Financial Results on Friday, March 27, 2026 (PR Newswire) +9.03%
Mar-15-26 08:00PM	51Talk Celebrates 15 Years with Global Brand Refresh and Debut of New Character Toki (PR Newswire)
Jan-23-26 02:50PM	DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event (ACCESSWIRE)
Dec-18-25 09:01AM	51Talk Empowers Young Voices at the United Nations Climate Stage (PR Newswire)
07:59AM	51Talk Brings Young Voices to the United Nations Climate Stage (PR Newswire)
Dec-16-25 07:01PM	51Talk Brings Young Voices to the United Nations Climate Stage (PR Newswire) -11.11%
Dec-08-25 06:35AM	51Talk Online Education Group Announces New Share Repurchase Program (PR Newswire) -12.20%
06:30AM	51Talk Online Education Group Announces Third Quarter 2025 Results (PR Newswire)
Dec-03-25 04:01PM	51Talk Online Education Group to Report Third Quarter 2025 Financial Results on Monday, December 8, 2025 (PR Newswire) -10.74% +11.38%
04:30AM	Loading…
Nov-19-25 04:30AM	51Talk Head of Strategy Discusses Global Expansion and AI-Driven Education Innovation on NYSE TV (PR Newswire)
Sep-04-25 11:00AM	51 Talk Online Education Group (COE) Q2 2025 Earnings Call Highlights: Surging Revenues Amidst ... (GuruFocus.com) +9.42%
Sep-03-25 06:30AM	51Talk Online Education Group Announces Engagement of Ernst & Young LLP, as the Company's Independent Registered Public Accounting Firm (PR Newswire)
05:00AM	51Talk Online Education Group Announces Second Quarter 2025 Results (PR Newswire)
Aug-29-25 06:00AM	51Talk Online Education Group to Report Second Quarter 2025 Financial Results on Wednesday, September 3, 2025 (PR Newswire)
Aug-19-25 08:00AM	Sidoti Events, LLC's Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-15-25 05:00AM	51Talk Online Education Group to Present at Sidoti Virtual Investor Conference on August 20-21, 2025 (PR Newswire) +5.52%
Jun-27-25 08:35AM	Small Cap Virtual Investor Conference: Now Available for Online Viewing (GlobeNewswire)
Jun-24-25 08:35AM	Small Cap Virtual Investor Conference Agenda Announced for June 26th (GlobeNewswire)
Jun-23-25 07:55PM	51Talk Online Education Group to Present at the Small Cap Growth Virtual Investor Conference June 26th, 2025 (PR Newswire) +8.91%
Jun-16-25 07:00AM	Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream (GlobeNewswire)
Jun-12-25 05:30AM	51Talk Online Education Group to Present on the Emerging Growth Conference on June 17, 2025. (PR Newswire) -11.04%
Jun-10-25 03:00AM	51 Talk Online Education Group (COE) Q1 2025 Earnings Call Highlights: Surging Revenues and ... (GuruFocus.com) +7.57%
Jun-09-25 06:00AM	51Talk Online Education Group Announces First Quarter 2025 Results (PR Newswire) +13.56%
Jun-05-25 07:00AM	51Talk Online Education Group to Report First Quarter 2025 Financial Results on Monday, June 9, 2025 (PR Newswire) +5.91%
08:35AM	Loading…
May-16-25 08:35AM	Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing (GlobeNewswire)
May-13-25 03:00AM	International companies to host live webcasts at Deutsche Banks Depositary Receipts Virtual Investor Conference on May 15, 2025 (GlobeNewswire)
May-12-25 08:00PM	International companies to host live webcasts at Deutsche Banks Depositary Receipts Virtual Investor Conference on May 15, 2025 (GlobeNewswire)
12:44PM	51Talk Online Education Group to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference May 15th (GlobeNewswire)
May-08-25 10:44AM	UPDATE - International companies to host live webcasts at Deutsche Banks Depositary Receipts Virtual Investor Conference on May 15, 2025 (GlobeNewswire)
08:35AM	International companies to host live webcasts at Deutsche Banks Depositary Receipts Virtual Investor Conference on May 15, 2025 (GlobeNewswire)
Apr-25-25 08:30PM	51Talk Online Education Group Files Annual Report on Form 20-F for Fiscal Year of 2024 (PR Newswire)
Mar-22-25 03:00AM	51 Talk Online Education Group (COE) Q4 2024 Earnings Call Highlights: Surging Revenues and ... (GuruFocus.com)
Mar-21-25 10:44AM	51Talk Online Education Group (COE) Q4 2024 Earnings Call Transcript (SeekingAlpha) -8.45%
06:10AM	51Talk Online Education Group Announces the Results for the Fourth Quarter and Full Year 2024 (PR Newswire)
Mar-19-25 03:40AM	51Talk Online Education Group to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, March 21, 2025 (PR Newswire)
Feb-25-25 12:56AM	How 51Talk is Redefining Online Education Through AI--from the Boardroom to the Classroom (PR Newswire)
Dec-15-24 10:00PM	51 Talk Online Education Group (COE) Q3 2024 Earnings Call Highlights: Surging Revenues and ... (GuruFocus.com)
Dec-14-24 07:17AM	51Talk Reports Robust Q3 2024 Growth Amid AI Adoption (TipRanks)
Dec-13-24 06:00AM	51Talk's Students Showcase Talent at COP29 (PR Newswire)
04:45AM	51Talk Online Education Group Announces Third Quarter 2024 Results (PR Newswire)
Dec-12-24 03:30AM	51Talk Online Education Group to Report Third Quarter 2024 Financial Results on Friday, December 13, 2024 (PR Newswire) +9.72%
Aug-23-24 05:30AM	51Talk Online Education Group Announces Second Quarter 2024 Results (PR Newswire)
Aug-22-24 05:30AM	51Talk Online Education Group to Report Second Quarter 2024 Financial Results on Friday, August 23, 2024 (PR Newswire) +9.70%
Jun-12-24 06:00AM	51Talk Online Education Group Announces First Quarter 2024 Results (PR Newswire)
Jun-10-24 05:00AM	51Talk Online Education Group to Report First Quarter 2024 Financial Results on Wednesday, June 12, 2024 (PR Newswire)
May-31-24 06:51AM	51Talk Online Education Group Announces Change to Board Composition (PR Newswire) +6.58%
Apr-29-24 09:00PM	51Talk Online Education Group Files Annual Report on Form 20-F for Fiscal Year 2023 (PR Newswire) +6.43%
Mar-22-24 06:00AM	51Talk Online Education Group Announces the Results for the Fourth Quarter and Full Year 2023 (PR Newswire)
Mar-20-24 05:00AM	51Talk Online Education Group to Report Fourth Quarter 2023 Financial Results on Friday, March 22, 2024 (PR Newswire) +10.33%
Dec-18-23 07:00AM	51Talk Online Education Group Announces Third Quarter 2023 Results (PR Newswire)
Dec-14-23 03:00AM	51Talk Online Education Group to Report Third Quarter 2023 Financial Results on Monday, December 18, 2023 (PR Newswire)
Aug-25-23 07:30AM	51Talk Online Education Group Announces Second Quarter 2023 Results (PR Newswire) +9.79%
Aug-23-23 07:00AM	51Talk Online Education Group to Report Second Quarter 2023 Financial Results on Friday, August 25, 2023 (PR Newswire)
May-23-23 08:00AM	51Talk Online Education Group Announces Transfer to NYSE American (PR Newswire)
Apr-26-23 06:00AM	51Talk Online Education Group Announces First Quarter 2023 Results (PR Newswire)
Apr-09-23 10:24AM	China Online Education Group (NYSE:COE) Q4 2022 Earnings Call Transcript (Insider Monkey)
Apr-06-23 08:50PM	51Talk Online Education Group Files Annual Report on Form 20-F for Fiscal Year 2022 (PR Newswire)
Mar-29-23 05:44AM	51Talk Online Education Group Announces the Results for the Third Quarter, the Fourth Quarter and Full Year 2022 (PR Newswire) +8.80%
Mar-28-23 06:10AM	51Talk Online Education Group to Report Third Quarter, Fourth Quarter and Fiscal Year 2022 Financial Results on Wednesday, March 29, 2023 (PR Newswire)
Dec-05-22 02:15AM	51Talk Online Education Group Announces ADS Ratio Change (PR Newswire)
Dec-01-22 05:29AM	Here's Why 51Talk Online Education Group (NYSE:COE) Has Caught The Eye Of Investors (Simply Wall St.)
Nov-29-22 05:30AM	Chinese Startups Try to Make It Big in the U.S.but Without the Backlash (The Wall Street Journal)
Nov-18-22 08:35AM	Deutsche Bank ADR Investor Conference: Presentations Now Available for On-Demand Viewing (GlobeNewswire)
Nov-16-22 08:40AM	51Talk Online Education Group to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 17 November 2022 (GlobeNewswire)
Nov-09-22 06:30PM	International companies to host live webcasts at Deutsche Banks Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2022 (GlobeNewswire)
Sep-30-22 05:00AM	51Talk Online Education Group's Name Is Approved and Adopted by Way of Annual General Meeting on September 30, 2022 (PR Newswire)
Sep-05-22 09:23PM	51Talk Announces Second Quarter 2022 Results: Strong Performance with Revenue Growing by 87.7% YoY (PR Newswire)
Aug-30-22 05:31AM	China Online Education Group Announces Second Quarter 2022 Results (PR Newswire) +5.72%
Aug-25-22 05:30AM	China Online Education Group to Report Second Quarter, 2022 Financial Results on Tuesday, August 30, 2022 (PR Newswire)
Aug-15-22 05:00AM	China Online Education Group Announces Engagement of Marcum Bernstein & Pinchuk LLP, a U.S. Auditor, as the Company's Independent Registered Public Accounting Firm (PR Newswire)
Aug-08-22 05:30AM	China Online Education Group to Hold an Annual General Meeting on September 30, 2022 (PR Newswire)
Jul-28-22 06:13AM	Insider Buying: The China Online Education Group (NYSE:COE) Founder Just Bought 86% More Shares (Simply Wall St.)
Jun-24-22 08:24AM	China Online Education Registers 90% Revenue Decline In Q1 (Benzinga) -11.11%
06:21AM	China Online Education Spins Off China Mainland Business (Benzinga)
05:00AM	China Online Education Group Announces First Quarter 2022 Results (PR Newswire)
04:32AM	China Online Education Group Enters into Definitive Agreement to Spin off China Mainland Business (PR Newswire)
Jun-22-22 04:30AM	China Online Education Group to Report First Quarter, 2022 Financial Results on Friday, June 24, 2022 (PR Newswire) +9.09%
May-12-22 09:54AM	Deutsche Banks Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewing (GlobeNewswire)
May-10-22 01:00AM	China Online Education Group Provides Update on Status under Holding Foreign Companies Accountable Act (PR Newswire)
May-08-22 08:30PM	International companies to host live webcasts at Deutsche Banks Depositary Receipts Virtual Investor Conference on May 10th and 11th, 2022 (GlobeNewswire)
May-05-22 08:58AM	International companies to host live webcasts at Deutsche Banks Depositary Receipts Virtual Investor Conference on May 10th and 11th, 2022 (GlobeNewswire) -7.53%
May-02-22 09:50PM	China Online Education Group Files Annual Report on Form 20-F for Fiscal Year 2021 (PR Newswire) +13.77%
Apr-11-22 05:00AM	China Online Education Group Announces Management Change (PR Newswire)
Mar-25-22 04:54AM	Shareholders in Cooper Energy (ASX:COE) are in the red if they invested three years ago (Simply Wall St.) -6.58%
Mar-24-22 06:24AM	China Online Education Group Announces Receipt of a Non-Binding Proposal to Acquire Mainland China Business of the Company (PR Newswire) -11.11%
06:23AM	/C O R R E C T I O N -- China Online Education Group/ (PR Newswire)
Mar-23-22 05:02AM	/C O R R E C T I O N -- China Online Education Group/ (PR Newswire) +12.50%
Dec-21-21 05:00AM	China Online Education Group Announces Receipt of NYSE Non-Compliance Letter (PR Newswire) -9.40%
Nov-19-21 10:59AM	Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewing (PR Newswire)
Nov-11-21 08:35AM	International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2021 (PR Newswire)
Oct-05-21 06:35AM	China Online Education Group (NYSE:COE) Not Doing Enough For Some Investors As Its Shares Slump 31% (Simply Wall St.)
Oct-01-21 07:08AM	China Online Education Group (NYSE:COE) shareholders have endured a 87% loss from investing in the stock five years ago (Simply Wall St.)
Sep-28-21 06:14AM	China Online Education Group Announces Second Quarter 2021 Results (PR Newswire) -8.42%
Sep-24-21 05:00AM	China Online Education Group to Report Second Quarter 2021 Financial Results on Tuesday, Sep 28, 2021 (PR Newswire) -6.00%

51Talk Online Education Group is a global online education platform focusing on English lessons. It operates through the following geographical segments: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia. The company was founded by Jia Jia Huang, Ting Shu, and Li Ming Zhang in July 2011 and is headquartered in Singapore.

FounderMr. Jiajia Huang

Co-Founder & DirectorMs. Ting Shu

Chief Financial OfficerMs. Chun Tang

Head of Investor RelationsMs. Judy Piao

Investor Relations Vice PresidentMr. David Chung

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Huang Jack Jiajia	Chief Executive Officer	Jul 07 '26	Buy	16.72	211,260	3,532,267	30,181,560	Jul 13 06:51 AM
Huang Jack Jiajia	Chief Executive Officer	Jul 08 '26	Buy	16.45	185,880	3,057,726	30,367,440	Jul 13 06:51 AM
Huang Jack Jiajia	Chief Executive Officer	Jul 06 '26	Buy	16.46	165,420	2,722,813	29,970,300	Jul 13 06:51 AM
Huang Jack Jiajia	Chief Executive Officer	Jul 02 '26	Buy	16.78	556,020	9,330,016	29,804,880	Jul 08 08:44 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 30 '26	Buy	15.90	353,580	5,622,607	28,962,060	Jul 08 08:44 AM
Huang Jack Jiajia	Chief Executive Officer	Jul 01 '26	Buy	16.57	286,800	4,752,276	29,248,860	Jul 08 08:44 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 29 '26	Buy	15.22	248,520	3,782,446	28,608,480	Jul 08 08:44 AM
Wu Xiaoguang	Director	Jul 01 '26	Option Exercise	0.00	45,911	0	1,404,198	Jul 02 07:04 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 30 '26	Option Exercise	0.00	275,000	0	42,251,300	Jun 30 08:03 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 24 '26	Buy	15.26	512,220	7,816,934	28,057,500	Jun 30 08:03 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 23 '26	Buy	15.96	248,400	3,963,878	27,545,280	Jun 30 08:03 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 25 '26	Buy	15.76	150,600	2,373,456	28,208,100	Jun 30 08:03 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 26 '26	Buy	15.61	151,860	2,370,489	28,359,960	Jun 30 08:03 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 18 '26	Buy	17.38	97,860	1,700,550	27,222,360	Jun 26 08:23 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 22 '26	Buy	15.96	74,520	1,189,613	27,296,880	Jun 26 08:23 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 16 '26	Buy	18.89	51,600	974,724	27,084,540	Jun 26 08:23 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 17 '26	Buy	17.20	39,960	687,312	27,124,500	Jun 26 08:23 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 12 '26	Buy	20.20	89,160	1,801,032	27,012,300	Jun 18 06:58 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 09 '26	Buy	21.89	35,880	785,413	26,875,860	Jun 18 06:58 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 11 '26	Buy	22.10	29,700	656,370	26,923,140	Jun 18 06:58 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 08 '26	Buy	22.34	23,340	521,416	26,839,980	Jun 18 06:58 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 15 '26	Buy	19.63	20,640	405,163	27,032,940	Jun 18 06:58 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 10 '26	Buy	22.82	17,580	401,176	26,893,440	Jun 18 06:58 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 02 '26	Buy	25.23	56,700	1,430,541	26,777,640	Jun 10 07:39 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 01 '26	Buy	25.57	48,300	1,235,031	26,720,940	Jun 10 07:39 AM
Huang Jack Jiajia	Chief Executive Officer	May 29 '26	Buy	25.74	21,240	546,718	26,672,640	Jun 10 07:39 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 04 '26	Buy	23.59	15,420	363,758	26,801,940	Jun 10 07:39 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 05 '26	Buy	22.74	14,700	334,278	26,816,640	Jun 10 07:39 AM
Huang Jack Jiajia	Chief Executive Officer	Jun 03 '26	Buy	24.61	8,880	218,537	26,786,520	Jun 10 07:39 AM
Lai Jimmy Y.	Director	Jun 01 '26	Option Exercise	0.00	50,336	0	2,982,236	Jun 01 07:55 AM
Huang Jack Jiajia	Chief Executive Officer	May 22 '26	Buy	26.76	74,280	1,987,733	26,542,680	Jun 01 07:28 AM
Huang Jack Jiajia	Chief Executive Officer	May 27 '26	Buy	26.39	45,840	1,209,718	26,626,020	Jun 01 07:28 AM
Huang Jack Jiajia	Chief Executive Officer	May 26 '26	Buy	26.28	37,500	985,500	26,580,180	Jun 01 07:28 AM
Huang Jack Jiajia	Chief Executive Officer	May 28 '26	Buy	26.19	25,380	664,702	26,651,400	Jun 01 07:28 AM
Huang Jack Jiajia	Chief Executive Officer	May 15 '26	Buy	26.34	47,280	1,245,355	26,360,460	May 26 07:29 AM
Huang Jack Jiajia	Chief Executive Officer	May 20 '26	Buy	27.13	45,600	1,237,128	26,439,840	May 26 07:29 AM
Huang Jack Jiajia	Chief Executive Officer	May 21 '26	Buy	26.97	28,560	770,263	26,468,400	May 26 07:29 AM
Huang Jack Jiajia	Chief Executive Officer	May 18 '26	Buy	28.00	22,440	628,320	26,382,900	May 26 07:29 AM
Huang Jack Jiajia	Chief Executive Officer	May 19 '26	Buy	26.87	11,340	304,706	26,394,240	May 26 07:29 AM
Huang Jack Jiajia	Chief Executive Officer	May 18 '26	Option Exercise	0.00	137,500	0	41,976,300	May 19 08:01 AM
Huang Jack Jiajia	Chief Executive Officer	May 14 '26	Buy	25.22	30,000	756,600	26,313,180	May 19 08:01 AM
Huang Jack Jiajia	Chief Executive Officer	May 12 '26	Buy	25.50	28,560	728,280	26,263,560	May 19 08:01 AM
Huang Jack Jiajia	Chief Executive Officer	May 13 '26	Buy	25.32	19,620	496,778	26,283,180	May 19 08:01 AM
Huang Jack Jiajia	Chief Executive Officer	May 11 '26	Buy	26.42	6,000	158,520	26,235,000	May 19 08:01 AM
Huang Jack Jiajia	Chief Executive Officer	May 08 '26	Buy	23.49	73,080	1,716,649	26,229,000	May 13 07:30 AM
Huang Jack Jiajia	Chief Executive Officer	May 07 '26	Buy	25.01	24,180	604,742	26,155,920	May 13 07:30 AM
Huang Jack Jiajia	Chief Executive Officer	May 06 '26	Buy	27.16	22,140	601,322	26,131,740	May 13 07:30 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 27 '26	Buy	26.30	161,280	4,241,664	25,863,900	May 08 04:08 PM
Huang Jack Jiajia	Chief Executive Officer	May 04 '26	Buy	28.79	83,580	2,406,268	26,098,020	May 08 04:08 PM
Huang Jack Jiajia	Chief Executive Officer	Apr 28 '26	Buy	26.99	64,500	1,740,855	25,928,400	May 08 04:08 PM
Huang Jack Jiajia	Chief Executive Officer	May 01 '26	Buy	29.05	52,560	1,526,868	26,014,440	May 08 04:08 PM
Huang Jack Jiajia	Chief Executive Officer	Apr 24 '26	Buy	26.07	39,720	1,035,500	25,702,620	May 08 04:08 PM
Huang Jack Jiajia	Chief Executive Officer	Apr 30 '26	Buy	28.36	24,180	685,745	25,961,880	May 08 04:08 PM
Huang Jack Jiajia	Chief Executive Officer	May 05 '26	Buy	28.06	11,580	324,935	26,109,600	May 08 04:08 PM
Huang Jack Jiajia	Chief Executive Officer	Apr 29 '26	Buy	27.87	9,300	259,191	25,937,700	May 08 04:08 PM
Huang Jack Jiajia	Chief Executive Officer	Apr 23 '26	Buy	25.71	73,740	1,895,855	25,662,900	Apr 27 08:16 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 21 '26	Buy	24.37	39,180	954,817	25,577,160	Apr 27 08:16 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 20 '26	Buy	23.59	21,480	506,713	25,537,980	Apr 27 08:16 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 22 '26	Buy	23.90	12,000	286,800	25,589,160	Apr 27 08:16 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 15 '26	Buy	25.69	166,560	4,278,926	25,432,020	Apr 22 04:03 PM
Huang Jack Jiajia	Chief Executive Officer	Apr 13 '26	Buy	22.22	72,720	1,615,838	25,204,260	Apr 22 04:03 PM
Huang Jack Jiajia	Chief Executive Officer	Apr 16 '26	Buy	25.79	60,420	1,558,232	25,492,440	Apr 22 04:03 PM
Huang Jack Jiajia	Chief Executive Officer	Apr 14 '26	Buy	24.36	61,200	1,490,832	25,265,460	Apr 22 04:03 PM
Huang Jack Jiajia	Chief Executive Officer	Apr 17 '26	Buy	25.51	24,060	613,771	25,516,500	Apr 22 04:03 PM
Wu Xiaoguang	Director	Apr 01 '26	Option Exercise	0.00	45,907	0	1,358,287	Apr 13 08:33 AM
Huang Jack Jiajia	Chief Executive Officer	Mar 30 '26	Option Exercise	0.00	275,000	0	41,838,800	Apr 13 08:31 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 01 '26	Buy	21.48	309,660	6,651,497	24,623,940	Apr 13 08:31 AM
Huang Jack Jiajia	Chief Executive Officer	Mar 30 '26	Buy	18.50	337,740	6,248,190	24,119,220	Apr 13 08:31 AM
Huang Jack Jiajia	Chief Executive Officer	Mar 27 '26	Buy	19.37	301,620	5,842,379	23,781,480	Apr 13 08:31 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 02 '26	Buy	22.21	170,520	3,787,249	24,794,460	Apr 13 08:31 AM
Huang Jack Jiajia	Chief Executive Officer	Mar 31 '26	Buy	19.09	195,060	3,723,695	24,314,280	Apr 13 08:31 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 09 '26	Buy	21.70	159,420	3,459,414	25,131,540	Apr 13 08:31 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 06 '26	Buy	22.96	117,660	2,701,474	24,912,120	Apr 13 08:31 AM
Huang Jack Jiajia	Chief Executive Officer	Mar 26 '26	Buy	18.35	88,560	1,625,076	23,479,860	Apr 13 08:31 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 08 '26	Buy	21.70	39,720	861,924	24,972,120	Apr 13 08:31 AM
Huang Jack Jiajia	Chief Executive Officer	Apr 07 '26	Buy	21.28	20,280	431,558	24,932,400	Apr 13 08:31 AM

Open in Screener

TDIC

Dreamland Ltd

3.14

Jul 17 • 04:43AM ET -0.13 (-3.98%)

Communication Services Advertising Agencies Hong Kong Nano NASD

Peers: BAOS CHR CNET DRCT KRKR VSME YDKG HAO SOPA STFS

Index	-
Market Cap	4.74M
Enterprise Value	2.41M
Income	-4.26M
Sales	7.02M
Book/sh	0.54
Cash/sh	2.34
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Jul 23, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	0.68
P/B	5.79
P/C	1.34
P/FCF	-
EV/EBITDA	-
EV/Sales	0.34
Quick Ratio	1.67
Current Ratio	1.68
Debt/Eq	0.30
LT Debt/Eq	0.18
Option/Short	No / Yes

EPS (ttm)	-0.56
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	256.99% -
EPS Y/Y TTM	-422.78%
Sales Y/Y TTM	14.95%
EPS Q/Q	-1242.32%
Sales Q/Q	28.78%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	97.27%
Insider Trans	79.84%
Inst Own	0.01%
Inst Trans	-
ROA	-55.47%
ROE	-181.62%
ROIC	-89.77%
Gross Margin	9.69%
Oper. Margin	-71.35%
Profit Margin	-60.65%
SMA20	-34.62%
SMA50	-85.98%
SMA200	-94.94%
Trades

Shs Outstand	7.20M
Shs Float	1.03M
Short Float	0.90%
Short Ratio	0.01
Short Interest	0.01M
52W High	987.50 -99.68%
52W Low	3.00 4.67%
Volatility	8.39% 20.41%
ATR (14)	5.14
RSI (14)	45.36
Beta	6.12
Rel Volume	0.11
Avg Volume	1.64M
Volume	9,401

Perf Week	-14.67%
Perf Month	-58.68%
Perf Quarter	-81.61%
Perf Half Y	-87.37%
Perf YTD	-86.47%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	3.27
Price	3.14
Change	-3.98%

Jul-01-26 01:02PM	Compromised Advisor Credentials Used in Pump-and-Dump Schemes (Wealth Management) -5.48%
May-15-26 10:30AM	BC-Most Active Stocks (Associated Press) +30.00%
May-13-26 10:30AM	BC-Most Active Stocks (Associated Press) +876.69%
May-12-26 11:13AM	AI Image Platform Partnership Expands Dreamlands Push Beyond Event Management (TDIC) (InvestorsHub) +126.92%
10:30AM	BC-Most Active Stocks (Associated Press)
05:12AM	Loading…
05:12AM	Dreamland Limited's Subsidiary Trendic International Limited and LinkFung Innovation Limited Enter Into MoU to Explore Development, Implementation, and Deployment of a Comprehensive AI-Powered Intelligent Image Library Platform (GlobeNewswire)
Apr-07-26 10:30AM	BC-Most Active Stocks (Associated Press) +45.11%
Dec-05-25 07:55AM	Dreamland Limited Secures $18 Million Equity Purchase Agreement (GlobeNewswire) +40.21%
Nov-28-25 06:16AM	Dreamland Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire) +9.82%
Jul-24-25 03:17PM	Dreamland Limited Announces Closing of Initial Public Offering (GlobeNewswire)
Jul-22-25 02:38PM	Dreamland Limited Announces Pricing of Initial Public Offering (GlobeNewswire)

Dreamland Ltd. is an event management service provider specializing in the organization, planning, promotion, and management of themed experience events. It handles a wide variety of public and private events, including trade shows, conferences, concerts, exhibitions, charity galas, brand promotions, and internal corporate events. The company was founded by Seto Wai Yue in 2016 and is headquartered in Hong Kong.

FounderMs. Wai Yue Seto

Chief Financial OfficerMr. Wai Kit Lee

Head of Design & Merchandising Department and DirectorMs. Sze Man Tse

General ManagerMr. Kai Chung Luk

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Seto Wai Yue	Chief Executive Officer	Jul 07 '26	Buy	3.75	652,000	2,445,000	749,890	Jul 13 06:05 AM

Peers: CRML EMAT MP ALM USAR TMC UAMY BHP RIO FCX

| Held by: REMX APIE WEPN MSSM CCSO WDIG

Index	-
Market Cap	826.18M
Enterprise Value	764.81M
Income	-53.95M
Sales	0.00M
Book/sh	3.22
Cash/sh	1.82
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Jun 21, 2022

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	7.09
P/C	12.55
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	4.00
Current Ratio	4.03
Debt/Eq	0.04
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	-1.63
EPS next Y	-0.24
EPS next Q	-0.35
EPS this Y	-646.65%
EPS next Y	72.87%
EPS next 5Y	-
EPS past 3/5Y	9.31% -49.42%
Sales past 3/5Y	- -
EPS Y/Y TTM	-48.46%
Sales Y/Y TTM	-
EPS Q/Q	-73.26%
Sales Q/Q	-
Earnings	Mar 12 BMO
EPS/Sales Surpr.	-150.00% -100.00%

Insider Own	-
Insider Trans	-
Inst Own	13.07%
Inst Trans	-12.22%
ROA	-44.04%
ROE	-50.48%
ROIC	-48.36%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-14.39%
SMA50	-31.71%
SMA200	-40.73%
Trades

Shs Outstand	36.22M
Shs Float	33.93M
Short Float	2.25%
Short Ratio	2.55
Short Interest	0.76M
52W High	61.45 -62.88%
52W Low	21.66 5.31%
Volatility	5.40% 6.52%
ATR (14)	1.93
RSI (14)	31.35
Beta	1.64
Rel Volume	0.01
Avg Volume	299.40K
Volume	148

Perf Week	-8.87%
Perf Month	-28.27%
Perf Quarter	-31.73%
Perf Half Y	-54.01%
Perf YTD	-36.96%
Perf Year	-35.13%
Perf 3Y	205.76%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	58.95
Prev Close	23.26
Price	22.81
Change	-1.93%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-27-26	Initiated	BTIG Research	Buy	$40
Jan-13-26	Initiated	William Blair	Outperform
Aug-20-25	Initiated	Roth Capital	Buy	$64
Oct-10-24	Initiated	B. Riley Securities	Buy	$30

Jul-07-26 07:51PM	IperionX Announces Pricing of Public Offering of American Depositary Shares (GlobeNewswire) -8.85% -7.70%
Jul-02-26 08:30AM	IperionX Completes Strategic Camden Acquisition - Unlocking Ultra-High-Grade Critical Minerals to Accelerate U.S. Supply Chain (GlobeNewswire)
Jul-01-26 08:30AM	IperionX Awarded Up to US$6.6M by OSW-SWIB to Scale U.S. Titanium Plate for Defense Applications (GlobeNewswire)
Jun-15-26 08:30AM	IperionX to Acquire Rights to Rare Earth and Critical Mineral Assets Adjacent to Titan Project (GlobeNewswire)
Jun-10-26 08:30AM	IperionX: Titan Definitive Feasibility Study (DFS) Presentation (GlobeNewswire) -5.13%
08:00AM	Loading…
Jun-04-26 08:00AM	IperionX Titan DFS Confirms High-Return U.S. Rare Earths and Critical Minerals Project (GlobeNewswire)
Jun-01-26 08:30AM	U.S. Army Testing Shows Iperionx Titanium Fasteners Exceed Grade 8 Steel Torque-To-Yield Performance (GlobeNewswire) +7.76%
May-21-26 08:30AM	IperionX Commissions Six-Axis Powder Metallurgy Press, Expanding U.S. Titanium Component Manufacturing Capabilities (GlobeNewswire)
May-04-26 11:45AM	Tungsten Reshoring Goes Public: Western Star Files DIBC Application as APT Prices Surge ~900% YoY and the U.S. Defense Procurement Cliff Closes In (PR Newswire)
Apr-27-26 09:00AM	Iperionx Webinar - Investor Update (GlobeNewswire) +10.94%
08:30AM	IperionX - March 2026 Quarterly Report (GlobeNewswire)
Mar-30-26 09:51AM	Iperionx - Change of Directors and Officers Ownership (GlobeNewswire)
Mar-18-26 08:00AM	Small Ohio Company's Chemistry Breakthrough Could Have Major Defense Implications (PR Newswire) -6.58%
Mar-16-26 11:30AM	IperionX Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses (Newsfile) -15.57%
Mar-13-26 10:50AM	America Is Closing the Gap in the Rare Earth Supply Chain Race - OilPrice.com Market Commentary (PR Newswire) -14.03%
12:01AM	Loading…
Mar-05-26 12:01AM	IPX- A Titanium Play for this Supply Shortfall Era (MoneyShow)
Mar-04-26 09:40AM	Has First Majestic Silver (AG) Outpaced Other Basic Materials Stocks This Year? (Zacks)
Feb-27-26 05:00AM	Magnet Wars: How the U.S. Plans to Break Chinas Grip on Rare Earths (Oilprice.com)
Feb-02-26 09:55AM	Does IperionX Limited Sponsored ADR (IPX) Have the Potential to Rally 28.18% as Wall Street Analysts Expect? (Zacks)
08:30AM	IperionX - 2026 Letter to Shareholders (GlobeNewswire)
Jan-30-26 08:30AM	IperionX - December 2025 Quarterly Report (GlobeNewswire) -5.45%
Jan-27-26 07:57AM	3 Rare Earth Stocks to Watch as USAR Rallies on Washington Support (Zacks)
Jan-25-26 06:50PM	IperionX (IPX) Climbs 28.4% on New Govt Deal (Insider Monkey)
Jan-23-26 09:40AM	Is IperionX Limited Sponsored ADR (IPX) Outperforming Other Basic Materials Stocks This Year? (Zacks) +8.01%
Jan-22-26 08:30AM	IperionX Receives Prototype Purchase Order for U.S. Army Heavy Ground Combat Systems (GlobeNewswire) +7.31%
Jan-16-26 08:30AM	IperionX Receives Final $4.6M In DoW Funding and 290 Metric Tons of Titanium Scrap from U.S. Government (GlobeNewswire)
Dec-15-25 08:30AM	IperionX and Carver Pump to Accelerate Critical Component Production for U.S. Navy Ships (GlobeNewswire) -5.02%
Nov-17-25 08:30AM	IperionX Response to Short Seller Report (GlobeNewswire)
Oct-30-25 08:30AM	IperionX - September 2025 Quarterly Report (GlobeNewswire)
Sep-27-25 08:40AM	IperionX receives $25M in U.S. funding to accelerate titanium production (TipRanks)
08:30AM	Loading…
Sep-26-25 08:30AM	IperionX Receives a Further $25M in U.S. Government Funding to Accelerate Titanium Production Scale-Up (GlobeNewswire) +5.36%
Sep-09-25 01:02AM	Iperionx Ltd (IPX) Ramping up Titanium Buildout Amid Soaring Demand (Insider Monkey) -9.86%
Sep-02-25 08:30AM	IperionX Accelerates U.S. Titanium Buildout to Deliver Largest Scale and Lowest Unit-Cost Production (GlobeNewswire)
Aug-26-25 08:30AM	IperionX Receives $12.5M U.S. Government Funding to Accelerate Expansion of U.S. Titanium Production (GlobeNewswire)
Aug-07-25 08:30AM	IperionX Granted Up to US$150 Million in Tax-Exempt Private Activity Bond Issuance Capacity (GlobeNewswire)
Jul-25-25 09:40AM	Is Crown Holdings (CCK) Stock Outpacing Its Industrial Products Peers This Year? (Zacks)
Jul-23-25 08:30AM	IperionX - June 2025 Quarterly Report (GlobeNewswire) +6.96%
Jul-14-25 12:54PM	Fastenal Q2 Earnings & Sales Beat Estimates, Stock Rises (Zacks)
Jun-11-25 08:30AM	IperionX Secures First U.S. Army Task Order Under US$99 Million SBIR Phase III Contract (GlobeNewswire)
Jun-10-25 07:30AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
Jun-05-25 08:30AM	IperionX Awarded U.S. Department of Defense SBIR Phase III Contract for Up to US$99M (GlobeNewswire) +19.74%
May-05-25 12:50PM	Fidelity International Discovery Fund Q1 2025 Commentary (Seeking Alpha)
Apr-15-25 08:30AM	IperionX March 2025 Quarterly Report (Business Wire) +14.66%
Apr-08-25 08:30AM	IperionX Commences Titan Critical Minerals Project Definitive Feasibility Study With U.S. Government Support (Business Wire) -5.87%
Apr-01-25 08:30AM	IperionX Receives U.S. EXIM Bank Board Approval for a $11M Loan to Produce All-American Titanium Products (Business Wire)
Mar-13-25 08:30AM	IperionX Interim Financial Report for the Six Months Ended December 31, 2024 (Business Wire)
Mar-11-25 08:30AM	IperionX Enhances Board With Appointment of Senior U.S. Directors (Business Wire)
Feb-18-25 08:30AM	IperionX Awarded $47.1M by the U.S. DoD to Secure U.S. Titanium Supply Chains (Business Wire) +15.12%
Feb-06-25 08:30AM	IperionX Letter to Shareholders (Business Wire)
Jan-28-25 08:30AM	IperionX December 2024 Quarterly Report (Business Wire)
Nov-26-24 08:30AM	IperionX Completes Acquisition of Breakthrough Titanium Technologies (Business Wire)
Aug-14-24 08:30AM	IperionX Achieves Major Milestone With First Successful Titanium Furnace Production Run (Business Wire) +6.84%
Jul-02-24 12:00PM	IperionX and Aperam Partnership to Advance a Circular Titanium Supply Chain (Business Wire) +7.51%
May-01-24 08:30AM	IperionX and Vegas Fastener to Co-Produce Titanium Fasteners for U.S. Army (Business Wire)
Apr-26-24 08:30AM	IperionX Titanium HAMR Furnace Installation Complete (Business Wire)
Apr-15-24 08:30AM	IperionX Partners With United Stars for U.S. Sourced Titanium Manufacturing (Business Wire) -5.10%
Feb-14-24 08:30AM	IperionX Drives Towards Commercial Scale Titanium Metal Production (Business Wire) +10.47%
Jan-16-24 08:30AM	IperionX Letter to Shareholders (Business Wire)
Nov-29-23 09:00AM	IperionX 2023 Sustainability Report (Business Wire)
Nov-08-23 08:30AM	IperionX Completes US$16.7M Placement to Re-shore U.S. Titanium Production (Business Wire)
Nov-01-23 08:30AM	IperionX Receives US$12.7M U.S. Department of Defense Grant for Domestic Titanium Production (Business Wire) +18.69%
Oct-19-23 08:30AM	IperionX Receives US$11.5 Million LOI From EXIM Bank for U.S. Titanium Production (Business Wire) -13.77%
Oct-09-23 08:30AM	IperionX Company Presentation (Business Wire)
Oct-02-23 08:30AM	GKN Aerospace Partners With IperionX to Advance Sustainable Titanium Manufacturing (Business Wire)
Sep-07-23 08:30AM	IperionX to Produce Titanium Plate for U.S. Army Testing (Business Wire) +10.80%
Sep-06-23 08:30AM	IperionX and Heroux-Devtek Partner for Aerospace Titanium Recycling (Business Wire)
Aug-28-23 08:30AM	Titan Project Development Update (Business Wire)
Aug-23-23 08:30AM	IperionX Earns International Recognition With R&D 100 Award (Business Wire)
Aug-17-23 08:30AM	IperionX to Produce Titanium Plate for Testing by Lockheed Martin (Business Wire)
Aug-15-23 08:30AM	IperionX Receives Key Permits for Development of the Titanium & Rare Earth Mineral Rich Titan Project (Business Wire)
Jul-31-23 08:30AM	IperionX Receives Key Permits for Titanium Metal Production in Virginia (Business Wire)
Jul-10-23 08:30AM	IperionX and Aperam Recycling Partner to Create 100% Recycled Titanium Supply Chain (Business Wire)
Jun-15-23 08:00AM	IperionX Achieves First UL Validated 100% Recycled Titanium (Business Wire) -7.10%
Jun-13-23 08:00AM	IperionX to Produce Titanium Components for Ford Motor Company (Business Wire) +99.10%
Apr-27-23 08:30AM	IperionX Plans to Build the Worlds Largest 100% Recycled Titanium Metal Powder Facility By 2025 (Business Wire)
Apr-26-23 08:30AM	IperionX Releases Life Cycle Assessment of 100% Recycled Titanium Powder (Business Wire)
Apr-20-23 08:30AM	IperionX Green Hydrogen Market Assessment (Business Wire)
Mar-28-23 08:00AM	IperionX & Canyon Bicycles Partner to Implement Sustainability Improvements in the Bicycle Industry Supply Chain (Business Wire)

IperionX Ltd. engages in the development of low carbon titanium for advanced industries, including space, aerospace, electric vehicles and 3D printing. It produces titanium metal powders from titanium scrap at its operational pilot facility in Utah and intends to scale production at a Titanium Demonstration Facility in Virginia. The company was founded by Anastasios Arima and Scott Sparks on May 5, 2017 and is headquartered in Charlotte, NC.

B.E.Mr. Todd William Hannigan B. Eng (Hons)

FounderMr. Anastasios Arima B.Com.

President & Chief Strategy OfficerMr. Toby Edgcumbe Symonds

Co-founder & Chief Operating OfficerMr. W. Scott Sparks

Chief Financial OfficerMs. Marcela Rocha Barbosa De Castro

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wyse Beverly	Director	Jul 15 '26	Option Exercise	0.87	106,093	92,301	745,868	Jul 15 09:23 AM
Arima Anastasios	Chief Executive Officer	Jul 10 '26	Buy	3.58	138,720	497,228	12,455,502	Jul 13 08:38 AM
Hannigan Todd	Executive Chairman	Jul 13 '26	Buy	3.59	300,000	1,075,980	26,633,334	Jul 13 08:16 AM
Hannigan Todd	Executive Chairman	Jul 10 '26	Buy	3.58	225,000	805,185	26,333,334	Jul 13 08:16 AM
Arima Anastasios	Chief Executive Officer	Apr 28 '26	Buy	4.49	110,000	493,625	12,316,782	Apr 30 07:38 AM
Hannigan Todd	Executive Chairman	Apr 29 '26	Buy	4.20	260,000	1,091,766	26,108,334	Apr 29 09:51 PM
Hannigan Todd	Executive Chairman	Apr 28 '26	Buy	4.48	220,000	986,018	25,848,334	Apr 29 09:51 PM
Symonds Toby Edgcumbe	President	Mar 27 '26	Buy	23.87	11,000	262,552	11,000	Mar 30 09:23 AM
Tripeny R Tony	Director	Mar 27 '26	Buy	23.76	4,187	99,464	4,187	Mar 30 09:08 AM
Hannigan Todd	Director	Mar 27 '26	Buy	3.20	225,225	720,923	25,628,334	Mar 30 08:57 AM
Arima Anastasios	Chief Executive Officer	Mar 27 '26	Buy	3.74	479,800	1,793,110	12,206,782	Mar 30 08:38 AM

CMC Commercial Metals Co daily Stock Chart

Peers: ATI CLF GGB NUE STLD RS TX MT SID AA

| Held by: IJH VTI IWM XME VB VBR VXF IWN PAVE MDY

Index	RUT
Market Cap	7.35B
Enterprise Value	10.41B
Income	595.11M
Sales	8.85B
Book/sh	40.94
Cash/sh	5.09
Dividend Est.	0.76 (1.14%)
Dividend TTM	0.76 (1.14%)
Dividend Ex-Date	Jul 06, 2026
Dividend Gr. 3/5Y	8.74% 8.45%
Payout	97.02%
Employees	12690
IPO	Jul 06, 1962

P/E	12.51
Forward P/E	9.41
PEG	0.32
P/S	0.83
P/B	1.62
P/C	13.04
P/FCF	18.14
EV/EBITDA	8.98
EV/Sales	1.18
Quick Ratio	1.54
Current Ratio	2.33
Debt/Eq	0.80
LT Debt/Eq	0.77
Option/Short	Yes / Yes

EPS (ttm)	5.31
EPS next Y	7.06
EPS next Q	1.96
EPS this Y	103.54%
EPS next Y	10.78%
EPS next 5Y	29.42%
EPS past 3/5Y	-57.90% -20.41%
Sales past 3/5Y	-4.36% 7.33%
EPS Y/Y TTM	1535.96%
Sales Y/Y TTM	15.23%
EPS Q/Q	111.57%
Sales Q/Q	22.93%
Earnings	Jun 25 BMO
EPS/Sales Surpr.	1.84% 3.40%

Insider Own	0.85%
Insider Trans	-1.55%
Inst Own	95.30%
Inst Trans	1.98%
ROA	7.09%
ROE	13.79%
ROIC	7.42%
Gross Margin	18.24%
Oper. Margin	9.08%
Profit Margin	6.72%
SMA20	0.54%
SMA50	-5.97%
SMA200	-2.29%
Trades

Shs Outstand	110.70M
Shs Float	109.68M
Short Float	4.24%
Short Ratio	3.91
Short Interest	4.65M
52W High	84.87 -21.76%
52W Low	49.66 33.71%
Volatility	2.68% 3.43%
ATR (14)	2.16
RSI (14)	47.81
Beta	1.53
Rel Volume	0.00
Avg Volume	1.19M
Volume	5

Perf Week	6.00%
Perf Month	-13.42%
Perf Quarter	3.69%
Perf Half Y	-10.58%
Perf YTD	-4.07%
Perf Year	26.48%
Perf 3Y	20.33%
Perf 5Y	120.67%
Perf 10Y	271.16%
Recom	1.79
Target Price	80.09
Prev Close	66.40
Price	66.40
Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-08-26	Upgrade	BNP Paribas Exane	Neutral → Outperform	$75
Jun-04-26	Downgrade	Wells Fargo	Overweight → Equal Weight	$77
May-22-26	Initiated	Barclays	Equal Weight	$75
May-14-26	Upgrade	UBS	Neutral → Buy	$89
Apr-01-26	Initiated	Goldman	Neutral	$74
Mar-25-26	Resumed	KeyBanc Capital Markets	Sector Weight
Dec-10-25	Upgrade	Jefferies	Hold → Buy	$78
Dec-05-25	Upgrade	JP Morgan	Neutral → Overweight	$78
Oct-24-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$68
Oct-22-25	Downgrade	Jefferies	Buy → Hold	$70
Oct-17-25	Upgrade	Citigroup	Neutral → Buy	$65
Aug-14-25	Initiated	Wells Fargo	Overweight	$61
May-30-25	Initiated	JP Morgan	Neutral	$52
May-27-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$50
Jan-10-25	Upgrade	UBS	Sell → Neutral	$56 → $54
Jan-03-25	Downgrade	Exane BNP Paribas	Outperform → Neutral
Dec-19-24	Resumed	Morgan Stanley	Equal-Weight	$65
Dec-12-24	Downgrade	UBS	Buy → Sell	$56
Dec-02-24	Initiated	Goldman	Buy	$75
Oct-09-24	Downgrade	Wolfe Research	Outperform → Peer Perform

Show Previous Ratings

Jun-25-26 07:00PM	Commercial Metals Co (CMC) Q3 2026 Earnings Call Highlights: Record Growth in Core EBITDA and ... (GuruFocus.com) -6.60%
06:53AM	Commercial Metals: Fiscal Q3 Earnings Snapshot (Associated Press)
06:45AM	CMC Reports Third Quarter of Fiscal 2026 Results (PR Newswire)
04:44AM	Earnings Calendar: McCormick results follow poor share price performance of late (MarketWatch)
Jun-24-26 08:34AM	CMC Announces Quarterly Dividend of $0.20 Per Share (PR Newswire)
09:58AM	Loading…
Jun-04-26 09:58AM	Broadcom downgraded, UnitedHealth upgraded: Wall Street's top analyst calls (The Fly)
May-27-26 06:45AM	CMC to Host 2026 Investor Day on August 5, 2026 (PR Newswire)
May-26-26 04:15PM	CMC Announces Third Quarter Fiscal 2026 Conference Call Webcast Details (PR Newswire)
May-14-26 10:24AM	Whats Next for Cleveland-Cliffs Stock? (Trefis)
Apr-14-26 06:25AM	JPMorgan tops earnings estimates on trading, investment banking strength (Proactive)
03:52AM	Nasdaq leads Wall Street higher as oil slides with Iran talks and earnings in focus (Proactive)
03:52AM	Nasdaq jumps, Dow heads higher with Iran talks and earnings in focus (Proactive)
03:52AM	Nasdaq jumps but Dow inches up with Iran talks and earnings in focus (Proactive)
03:52AM	Dow Jones set to open flat as Iran talks and bank earnings in focus (Proactive)
Apr-13-26 04:15PM	CMC Announces Appointment of Michael "Mike" Dumais to Board of Directors (PR Newswire)
10:15AM	Loading…
Apr-06-26 10:15AM	JPMorgan CEO Jamie Dimon warns of geopolitical, regulatory and AI risks in annual shareholder letter (Proactive)
10:15AM	JPMorgan CEO Dimon warns of geopolitical, regulatory and AI risks (Proactive)
Apr-01-26 07:18PM	US Set to Roll Out Tiered Tariffs on Steel, Aluminum Imports (Bloomberg)
Mar-26-26 04:43PM	Commercial Metals Company Q2 2026 Earnings Call Summary (Moby)
07:09AM	Commercial Metals Sees Further Growth In Second Half; Boosts Dividend 11% - Update (RTT News)
06:52AM	Commercial Metals: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
06:45AM	CMC Reports Second Quarter of Fiscal 2026 Results (PR Newswire)
05:31AM	Argan earnings on tap after shares surge 280% in just 12 months (MarketWatch)
04:18AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to retreat as oil rises on Day 26 of Iran conflict (MarketWatch)
Mar-25-26 08:49AM	CMC Announces an 11% Increase in Quarterly Dividend (PR Newswire)
Mar-19-26 03:52PM	JPMorgan analysts cut S&P 500 target, flagging market complacency despite oil shock (Proactive)
Mar-05-26 06:15PM	Methanex (MEOH) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Feb-26-26 04:15PM	CMC Announces Second Quarter Fiscal 2026 Conference Call Webcast Details (PR Newswire)
Feb-25-26 11:11AM	Is CMC's North America Steel Group Segment Set for Long-Term Growth? (Zacks)
09:12AM	Do Options Traders Know Something About Commercial Metals Stock We Don't? (Zacks)
11:13AM	Loading…
Feb-24-26 11:13AM	CMC vs. CRS: Which Steel Stock Is the Better Buy Right Now? (Zacks)
Feb-23-26 11:23AM	Can CRS's Brownfield Expansion Project Fuel Long-Term Growth? (Zacks)
Feb-18-26 11:35AM	Can Commercial Metals' TAG Program Drive Margin Expansion? (Zacks)
Feb-13-26 10:02AM	Stocks Edge Lower as AI Fears Linger (Barchart)
Feb-11-26 10:59AM	CMC Jumps 69% in a Year: What's the Right Strategy for Investors Now? (Zacks)
Feb-02-26 01:14PM	Carpenter Technology Q2 Earnings Beat Estimates, Revenues Rise 8% Y/Y (Zacks)
Jan-29-26 03:00PM	4 GARP Stocks With Attractive PEG Ratios and Strong Growth Outlooks (Zacks)
12:20PM	Earnings Estimates Rising for Commercial Metals (CMC): Will It Gain? (Zacks)
Jan-28-26 12:22PM	CMC vs. NUE: Which US Steel Giant Is the Better Buy Right Now? (Zacks)
Jan-27-26 04:52PM	CMC Named to Corporate Knights' 2026 Global 100 Most Sustainable Corporations (PR Newswire)
12:31PM	Can Commercial Metals' Recent Acquisitions Fuel Long-Term Growth? (Zacks)
09:40AM	Should Value Investors Buy Commercial Metals (CMC) Stock? (Zacks)
Jan-23-26 12:00PM	Commercial Metals (CMC) is a Great Momentum Stock: Should You Buy? (Zacks)
Jan-20-26 03:00PM	Avoid Value Traps and Buy These 4 PEG-Based Stocks Now (Zacks)
Jan-19-26 07:41AM	POSCO Advances Automation With Yaskawa Industrial Robots Deal (Zacks)
06:16AM	Best Growth Stocks to Buy for January 19th (Zacks)
Jan-16-26 01:18PM	JP Morgan Predicts Mixed Q4 Steel Earnings Despite Steel Rally (Benzinga)
08:38AM	4 Women-Run Company Stocks Building Durable Growth Stories (Zacks)
Jan-15-26 01:14PM	Goldman Sachs Lifts Commercial Metals Company (CMC) Price Target Buoyed By Position in Steel Market (Insider Monkey)
Jan-12-26 12:59PM	Should Commercial Metals Be Part of Your Portfolio Post Q1 Results? (Zacks)
Jan-09-26 12:45PM	Looking for a Growth Stock? 3 Reasons Why Commercial Metals (CMC) is a Solid Choice (Zacks)
06:59AM	5E Advanced Materials Boric Acid Validated for LCD Glass Applications (Zacks)
06:04AM	Best Growth Stocks to Buy for January 9th (Zacks)
Jan-08-26 06:00PM	Commercial Metals Co (CMC) Q1 2026 Earnings Call Highlights: Record Earnings and Strategic ... (GuruFocus.com)
02:20PM	Commercial Metals Q1 Earnings Call Highlights (MarketBeat)
09:43AM	Commercial Metals Warns Of Near-Term Profit Hit From Acquisition Costs, Seasonal Steel Slump (Benzinga)
09:31AM	Zacks.com featured highlights include Animal Health, Commercial Metals, Fox and Adtalem Global Education (Zacks)
09:30AM	Here's What Key Metrics Tell Us About Commercial Metals (CMC) Q1 Earnings (Zacks)
07:03AM	BASF Launches Key Steam Cracker at New Zhanjiang Verbund Site (Zacks)
06:56AM	Commercial Metals: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:51AM	Should You Buy, Sell or Hold CMC Stock Before Q1 Earnings Release? (Zacks)
06:45AM	CMC Reports First Quarter of Fiscal 2026 Results (PR Newswire)
05:45AM	Earnings to put Commercial Metals' recent share price surge to the test (MarketWatch)
05:12AM	Stock Market Today: Dow, S&P 500 and Nasdaq point to lower open; Nvidia in focus on China chip sales hope; precious metals retreat (MarketWatch)
Jan-07-26 03:00PM	4 PEG-Based GARP Picks for Navigating Early-2026 Market Uncertainty (Zacks)
04:42AM	Best Growth Stocks to Buy for January 7th (Zacks)
Jan-06-26 08:53AM	4 Steel Producer Stocks In Focus as Industry Gains on Price Recovery (Zacks)
04:10AM	Zacks.com featured highlights include Jabil, Ciena, Commercial Metals and Plains All American Pipeline (Zacks)
Jan-05-26 12:00PM	What Makes Commercial Metals (CMC) a Strong Momentum Stock: Buy Now? (Zacks)
09:30AM	Why Relative Price Strength Matters More Heading Into 2026 (Zacks)
06:45AM	CMC Announces Quarterly Dividend of $0.18 Per Share (PR Newswire)
Jan-04-26 07:45AM	December jobs numbers get data back on track during first full week of trading in 2026: What to watch (Yahoo Finance)
Jan-03-26 08:40AM	Stock Market Week Ahead: December Jobs, CES (Investor's Business Daily)
Jan-02-26 01:13PM	Acuity Stock, Fast-Growing Data Center Operator Headline 2026 Earnings Calendar (Investor's Business Daily)
Dec-29-25 12:20PM	Why Commercial Metals (CMC) Might be Well Poised for a Surge (Zacks)
09:20AM	Best Growth Stocks to Buy for December 29th (Zacks)
06:06AM	Zacks.com featured highlights include Ciena, EverQuote, PJT Partners and Commercial Metals (Zacks)
Dec-26-25 10:58AM	4 Top-Ranked Liquid Stocks to Enhance Portfolio Returns in 2026 (Zacks)
Dec-24-25 03:00PM	3 Attractive PEG-Driven Value Stocks to Pick for 2026 (Zacks)
12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Commercial Metals (CMC) (Zacks)
04:25AM	Best Growth Stocks to Buy for Dec. 24 (Zacks)
Dec-23-25 01:45PM	The Best Surging "Strong Buy" Stocks to Buy in 2026 (Zacks)
08:01AM	ICL Strengthens Food Ingredients Platform With Bartek Acquisition (Zacks)
Dec-19-25 12:11PM	Earnings Calendar Preview: Defense Stock AAR, Coatings Firm AZZ Lead January Profit Parade (Investor's Business Daily)
08:55AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Commercial Metals (CMC) (Zacks)
07:25AM	Steel Dynamics Projects Sequentially Lower Q4 Earnings on Seasonality (Zacks)
06:45AM	Commercial Metals Applauds Preliminary Ruling Against Algerian Rebar (PR Newswire)
Dec-18-25 04:15PM	CMC Publishes 2025 Sustainability Report (PR Newswire)
07:43AM	Nucor Expects Q4 Earnings to Dip on Seasonality, Stays Bullish on 2026 (Zacks)
Dec-17-25 04:15PM	Commercial Metals Announces Credit Facility Amendment (PR Newswire)
10:14AM	Can These 5 Relative Price Strength Stocks Lead in 2026? (Zacks)
09:40AM	Are Basic Materials Stocks Lagging Barrick Mining Corporation (B) This Year? (Zacks)
Dec-16-25 12:00PM	Commercial Metals (CMC) Is Up 5.53% in One Week: What You Should Know (Zacks)
07:04AM	5 High Earnings Yield Value Picks Ahead of Key Economic Reports (Zacks)
Dec-15-25 04:19PM	Commercial Metals Completes Acquisition of Foley Products Company (PR Newswire)
09:06AM	Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus (Zacks)
Dec-11-25 08:30AM	4 Steel Stocks That Have Gained More Than 40% YTD Amid Price Recovery (Zacks)
07:23AM	Best Growth Stocks to Buy for December 11th (Zacks)
04:07AM	Zacks.com featured highlights include Centerra Gold, Commercial Metals, Vista Energy and Credicorp (Zacks)
Dec-10-25 03:00PM	4 PEG-Based GARP Picks Positioned to Offer Consistent Returns (Zacks) +5.12%

Commercial Metals Co. engages in the manufacture, recycling, and marketing of steel and metal products. It operates through the North America and Europe segments. The North America segment focuses on the network of recycling facilities, steel mills, and fabrication operations. The Europe segment includes a network of recycling facilities, an EAF mini mill, and fabrication operations located in Poland. The company was founded by Moses Feldman in 1915 and is headquartered in Irving, TX.

CEOMr. Peter R. Matt

Senior VP & CFOMr. Paul J. Lawrence CPA

Senior VPMs. Jody K. Absher J.D.

Senior VP & Chief Strategy OfficerMr. Kekin M. Ghelani

Senior Vice President of Operational & Commercial ExcellenceMr. Ty L. Garrison

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MATT PETER R	President and CEO	Jul 10 '26	Buy	61.30	8,230	504,499	181,522	Jul 13 11:49 AM
DURBIN JENNIFER J	Fmr. Chief HR & Comm. Officer	Feb 03 '26	Sale	79.97	25,050	2,003,248	52,880	Feb 04 02:39 PM
DURBIN JENNIFER J	Former Officer	Feb 03 '26	Proposed Sale	79.97	25,050	2,003,248		Feb 03 10:37 AM
ARRIOLA DENNIS V	Director	Jan 20 '26	Buy	74.69	2,000	149,380	9,238	Jan 22 10:15 AM
Halloran Brian N.	SVP, N. America Steel Group	Oct 31 '25	Sale	59.87	6,232	373,110	58,055	Nov 04 08:41 AM
Halloran Brian N.	Officer	Oct 31 '25	Proposed Sale	59.87	6,232	373,120		Oct 31 12:52 PM
McPherson John R	Director	Oct 20 '25	Buy	58.09	1,722	100,037	6,722	Oct 21 01:15 PM

PRQR ProQR Therapeutics N.V daily Stock Chart

Peers: KPTI ADAG CAMP CNTN CNTX IFRX PLYX RNA TENX TLSA

Index	-
Market Cap	230.61M
Enterprise Value	152.95M
Income	-52.71M
Sales	15.53M
Book/sh	0.41
Cash/sh	0.68
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Sep 18, 2014

P/E	-
Forward P/E	-
PEG	-
P/S	14.85
P/B	4.06
P/C	2.47
P/FCF	-
EV/EBITDA	-
EV/Sales	9.85
Quick Ratio	2.48
Current Ratio	2.48
Debt/Eq	0.36
LT Debt/Eq	0.24
Option/Short	Yes / Yes

EPS (ttm)	-0.50
EPS next Y	-0.57
EPS next Q	-0.13
EPS this Y	-14.33%
EPS next Y	-9.31%
EPS next 5Y	4.83%
EPS past 3/5Y	21.80% 15.68%
Sales past 3/5Y	68.13% -
EPS Y/Y TTM	-44.36%
Sales Y/Y TTM	-23.73%
EPS Q/Q	-47.57%
Sales Q/Q	-49.99%
Earnings	May 12 BMO
EPS/Sales Surpr.	-9.12% -54.37%

Insider Own	32.63%
Insider Trans	1.01%
Inst Own	26.02%
Inst Trans	-1.64%
ROA	-37.92%
ROE	-81.98%
ROIC	-98.02%
Gross Margin	79.71%
Oper. Margin	-346.94%
Profit Margin	-339.39%
SMA20	-4.23%
SMA50	3.11%
SMA200	-10.79%
Trades

Shs Outstand	105.36M
Shs Float	93.02M
Short Float	1.29%
Short Ratio	1.21
Short Interest	1.20M
52W High	3.10 -46.13%
52W Low	1.33 25.56%
Volatility	7.05% 10.94%
ATR (14)	0.14
RSI (14)	49.11
Beta	0.07
Rel Volume	0.00
Avg Volume	987.64K
Volume	78

Perf Week	-3.47%
Perf Month	9.87%
Perf Quarter	-14.36%
Perf Half Y	1.83%
Perf YTD	-17.33%
Perf Year	-30.42%
Perf 3Y	-1.76%
Perf 5Y	-70.18%
Perf 10Y	-65.50%
Recom	1.00
Target Price	8.99
Prev Close	1.67
Price	1.67
Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-12-26	Resumed	Oppenheimer	Outperform	$9
Apr-29-25	Resumed	Cantor Fitzgerald	Overweight	$8
Apr-29-25	Initiated	Evercore ISI	Outperform	$5
Mar-10-25	Upgrade	Citigroup	Neutral → Buy	$4
Jan-10-25	Initiated	Oppenheimer	Outperform	$15
Oct-29-24	Upgrade	Raymond James	Outperform → Strong Buy	$6 → $14
Nov-08-23	Upgrade	Chardan Capital Markets	Neutral → Buy	$2
Mar-30-23	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$1.50 → $5
Dec-22-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$0.80 → $5
Feb-14-22	Downgrade	Citigroup	Buy → Neutral	$37 → $1.70
Feb-11-22	Downgrade	Stifel	Buy → Hold	$20 → $3
Feb-11-22	Downgrade	Raymond James	Strong Buy → Mkt Perform
Feb-01-22	Initiated	Raymond James	Strong Buy	$19
May-03-21	Initiated	Stifel	Buy	$20
Mar-25-21	Reiterated	Citigroup	Buy	$33 → $44
Nov-03-20	Resumed	Cantor Fitzgerald	Overweight	$22
Mar-12-19	Reiterated	Chardan Capital Markets	Buy	$21 → $25
Dec-19-18	Initiated	RBC Capital Mkts	Outperform
Nov-15-18	Initiated	Citigroup	Buy	$32
Sep-19-18	Initiated	Evercore ISI	Outperform

Show Previous Ratings

Jun-25-26 06:35AM	ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -13.54%
06:25AM	ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform (GlobeNewswire)
May-12-26 07:00AM	ProQR Announces First Quarter 2026 Operating and Financial Results (GlobeNewswire)
May-11-26 08:00AM	ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer RNA Editing Platform (GlobeNewswire)
May-04-26 08:00AM	ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 (GlobeNewswire) +5.81%
08:00AM	Loading…
Apr-30-26 08:00AM	ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors (GlobeNewswire)
Apr-08-26 04:00PM	ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event (GlobeNewswire) +7.65% +8.20%
08:00AM	ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board (GlobeNewswire)
Mar-25-26 08:00AM	ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026 (GlobeNewswire) +6.04%
Mar-12-26 09:18AM	ProQR: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	ProQR Announces Year End 2025 Operating and Financial Results (GlobeNewswire)
Mar-10-26 08:30AM	Opus Genetics, Inc. (IRD) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Mar-03-26 04:30PM	ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference (GlobeNewswire) -5.06% +13.33%
Feb-26-26 06:45PM	Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-09-26 08:00AM	ProQR Announces Planned Changes to Board Composition (GlobeNewswire)
08:00AM	Loading…
Jan-08-26 08:00AM	ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook (GlobeNewswire)
Dec-01-25 08:00AM	ProQR to Participate in 8th Annual Evercore Healthcare Conference (GlobeNewswire) -9.40%
Nov-06-25 08:10AM	ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -7.14%
07:08AM	ProQR: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	ProQR Announces Third Quarter 2025 Operating and Financial Results (GlobeNewswire)
Oct-28-25 08:20AM	Alkermes (ALKS) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Oct-20-25 08:00AM	ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 (GlobeNewswire) +9.71%
Oct-13-25 08:30AM	ProQR to Participate in Upcoming Investor Conferences in October 2025 (GlobeNewswire)
Aug-08-25 02:02PM	ProQR: Q2 Earnings Snapshot (Associated Press Finance) +5.85%
Aug-07-25 08:40AM	Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
07:00AM	ProQR Announces Second Quarter 2025 Operating and Financial Results (GlobeNewswire)
Jul-28-25 08:00AM	ProQR Announces Upcoming Presentation at RNA Editing Summit (GlobeNewswire)
Jun-26-25 04:30PM	ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP (GlobeNewswire) -5.56%
May-12-25 08:00AM	ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences (GlobeNewswire)
May-08-25 07:00AM	ProQR Announces First Quarter 2025 Operating and Financial Results (GlobeNewswire)
07:40AM	Loading…
May-07-25 07:40AM	Techne (TECH) Q3 Earnings and Revenues Beat Estimates (Zacks)
May-02-25 08:00AM	ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference (GlobeNewswire) +15.70%
May-01-25 08:00AM	ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 (GlobeNewswire)
Apr-29-25 04:31PM	ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald (TipRanks) +5.84%
04:05PM	ProQR Therapeutics initiated with an Outperform at Evercore ISI (TipRanks)
Apr-15-25 09:01AM	Strength Seen in BioNTech (BNTX): Can Its 6.0% Jump Turn into More Strength? (Zacks)
Apr-14-25 07:00AM	ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth (GlobeNewswire) +5.36%
Mar-13-25 07:00AM	ProQR Announces Year End 2024 Operating and Financial Results (GlobeNewswire) -5.95%
Dec-12-24 07:16AM	ProQR Therapeutics announces $8.1M in new funding from RSRT (TipRanks)
Dec-11-24 07:00AM	ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration (GlobeNewswire)
Dec-10-24 08:00AM	ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist (GlobeNewswire)
Dec-06-24 06:47AM	ProQR Therapeutics price target raised to $8 from $5 at JMP Securities (TipRanks)
Dec-05-24 08:00AM	ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024 (GlobeNewswire)
Nov-08-24 07:26AM	ProQR Therapeutics sees cash runway into mid-2027 (TipRanks) +5.60%
Nov-07-24 07:00AM	ProQR Announces Third Quarter 2024 Operating and Financial Results (GlobeNewswire)
Oct-25-24 04:45PM	ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement (GlobeNewswire)
Oct-22-24 10:15PM	ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement (GlobeNewswire) -6.67% -7.67%
04:01PM	ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares (GlobeNewswire)
Oct-07-24 08:00AM	ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society (GlobeNewswire)
Sep-10-24 04:30PM	ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference (GlobeNewswire)
Aug-08-24 07:00AM	ProQR Announces Second Quarter 2024 Operating and Financial Results (GlobeNewswire) +12.30%
Jun-18-24 08:00AM	ProQR Announces Presentation on its Axiomer RNA Editing Technology at RNA Editing Summit (GlobeNewswire)
May-09-24 07:00AM	ProQR Announces First Quarter 2024 Operating and Financial Results (GlobeNewswire)
May-08-24 08:00AM	ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer RNA Editing Program Targeting NTCP for Cholestatic Diseases (GlobeNewswire)
Apr-23-24 07:00AM	ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 (GlobeNewswire)
Apr-22-24 04:31PM	ProQR Highlights Upcoming Presentations on Axiomer RNA Editing at ASGCT 27th Annual Meeting (GlobeNewswire)
Apr-19-24 07:00AM	ProQR Achieves Successful Defense of New Challenge to its Axiomer IP Portfolio (GlobeNewswire) +6.99%
Mar-13-24 07:00AM	ProQR Announces Year End 2023 Operating and Financial Results (GlobeNewswire) +13.66%
Feb-15-24 07:00AM	ProQR Announces Japanese Axiomer Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing (GlobeNewswire)
Jan-19-24 07:00AM	ProQR Highlights New Platform Data from Presentation on Axiomer RNA Editing Technology at Deaminet 2024 (GlobeNewswire)
Jan-05-24 07:00AM	ProQR and Rett Syndrome Research Trust Join Forces with Axiomer RNA Editing Collaboration (GlobeNewswire)
Dec-28-23 08:44AM	Is ProQR (PRQR) Stock a Solid Choice Right Now? (Zacks)
Dec-08-23 07:30AM	ProQR Therapeutics Announces Transaction Completed for Th a to Acquire Sepofarsen and Ultevursen Ophthalmic Assets (GlobeNewswire)
Nov-07-23 07:00AM	ProQR Announces Third Quarter 2023 Operating and Financial Results (GlobeNewswire) +10.66%
Nov-06-23 07:00AM	ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing (GlobeNewswire)
Sep-28-23 08:00AM	ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-27-23 07:00AM	ProQR Therapeutics Provides Update on Ophthalmic Assets (GlobeNewswire)
Sep-07-23 08:00AM	ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-08-23 06:37AM	ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are retail investors with 50% stake, while 31% is held by institutions (Simply Wall St.)
Aug-03-23 07:00AM	ProQR Announces Second Quarter 2023 Operating and Financial Results (GlobeNewswire)
Aug-01-23 07:00AM	ProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQRs Sepofarsen and Ultevursen Ophthalmic Assets (GlobeNewswire) +7.33%
Jul-06-23 07:00AM	ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit (GlobeNewswire)
Jun-28-23 06:02AM	ProQR Therapeutics' (NASDAQ:PRQR) investors will be pleased with their impressive 109% return over the last year (Simply Wall St.)
May-18-23 07:02AM	ProQR Therapeutics N.V. (NASDAQ:PRQR) Could Be Less Than A Year Away From Profitability (Simply Wall St.)
May-16-23 07:00AM	ProQR Announces First Quarter 2023 Operating and Financial Results (GlobeNewswire) -7.29%
May-09-23 08:00AM	ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 (GlobeNewswire)
Apr-20-23 08:00AM	ProQR Announces Upcoming Investor Conferences in April and May (GlobeNewswire)
Apr-18-23 08:00AM	ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023 (GlobeNewswire) -6.47%
Mar-29-23 12:30PM	Why Shares of ProQR Therapeutics Dropped on Wednesday (Motley Fool) -29.61%
08:00AM	ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event (GlobeNewswire)
Mar-14-23 08:00AM	ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing (GlobeNewswire) +7.85%
Mar-07-23 08:00AM	ProQR to Present at Upcoming Scientific and Industry Conferences (GlobeNewswire)
Feb-28-23 08:00AM	ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 (GlobeNewswire)
Feb-01-23 05:11AM	Individual investors account for 45% of ProQR Therapeutics N.V.'s (NASDAQ:PRQR) ownership, while institutions account for 35% (Simply Wall St.)
Dec-29-22 11:36AM	Biotech Stock Roundup: GILD's HIV Drug Approval, PRQR Surges on LLY Deal & More (Zacks) +10.13%
Dec-23-22 12:14PM	ProQR (PRQR) Rises on Expanding RNA-Editing Deal With Eli Lilly (Zacks)
Dec-22-22 09:12AM	ProQR's stock jumps on expanded RNA deal with Lilly (MarketWatch) +63.64%
08:53AM	ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration (Benzinga)
06:15AM	ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform (GlobeNewswire)
06:00AM	Lilly and ProQR to Expand RNA Editing Collaboration (PR Newswire)
05:28AM	ProQR Therapeutics (NASDAQ:PRQR) shareholders have endured a 83% loss from investing in the stock three years ago (Simply Wall St.)
Nov-14-22 04:30PM	ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022 (GlobeNewswire) +5.18%
Nov-11-22 05:54AM	ProQR Therapeutics Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Nov-09-22 08:25AM	ProQR (PRQR) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:00AM	ProQR Announces Third Quarter 2022 Operating and Financial Results (GlobeNewswire)
Nov-03-22 07:00AM	ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference (GlobeNewswire)
Aug-12-22 02:05PM	Raymond James Bullish On This Penny Stock's Reprioritized Pipeline (Benzinga) +5.51%
Aug-11-22 02:48PM	This Penny Stock Biotech Offloads Eye Portfolio To Focus On RNA-Editing (Benzinga)
07:00AM	ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs (GlobeNewswire)
Aug-04-22 10:25AM	ProQR (PRQR) Reports Q2 Loss, Lags Revenue Estimates (Zacks)

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.

FounderMr. Daniel Anton de Boer

Co-FounderDr. Gerard Platenburg Ph.D.

Chief Financial OfficerMr. Dennis Hom

Chief People & Operations OfficerMs. Sheila Sponselee

Vice President of Investor Relations & Corporate CommunicationsMs. Sarah Cue Kiely

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
de Boer Daniel Anton	Chief Executive Officer	Jul 09 '26	Buy	1.74	150,000	261,000	300,000	Jul 13 08:00 AM
de Boer Daniel Anton	Chief Executive Officer	Jul 07 '26	Buy	1.59	150,000	238,500	150,000	Jul 08 02:55 PM
Filius Bart	Director	Jun 26 '26	Buy	1.54	150,000	231,000	150,000	Jun 30 04:01 PM

Open in Screener

CRDF

Cardiff Oncology Inc

0.8720

Jul 17 • 04:00AM ET -0.0025 (-0.29%)

Healthcare Biotechnology USA Micro NASD

CRDF Cardiff Oncology Inc daily Stock Chart

Peers: AARD AGEN BMEA CNTB GALT IMUX KZIA NTHI SPRO VRCA

| Held by: VTI VXF IWC DFAC AVSC

Index	-
Market Cap	59.62M
Enterprise Value	14.21M
Income	-44.79M
Sales	0.53M
Book/sh	0.51
Cash/sh	0.67
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	31
IPO	Jul 27, 2004

P/E	-
Forward P/E	-
PEG	-
P/S	112.49
P/B	1.72
P/C	1.29
P/FCF	-
EV/EBITDA	-
EV/Sales	26.81
Quick Ratio	3.27
Current Ratio	3.27
Debt/Eq	0.02
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-0.67
EPS next Y	-0.82
EPS next Q	-0.12
EPS this Y	1.32%
EPS next Y	-20.42%
EPS next 5Y	-17.89%
EPS past 3/5Y	8.24% 8.71%
Sales past 3/5Y	15.39% 10.13%
EPS Y/Y TTM	28.59%
Sales Y/Y TTM	-10.71%
EPS Q/Q	10.54%
Sales Q/Q	-62.39%
Earnings	May 14 AMC
EPS/Sales Surpr.	-33.53% -53.72%

Insider Own	8.54%
Insider Trans	15.34%
Inst Own	30.02%
Inst Trans	-4.66%
ROA	-66.82%
ROE	-84.79%
ROIC	-128.96%
Gross Margin	-70.86%
Oper. Margin	-9033.90%
Profit Margin	-8530.86%
SMA20	-28.69%
SMA50	-40.30%
SMA200	-55.14%
Trades

Shs Outstand	68.37M
Shs Float	62.53M
Short Float	20.49%
Short Ratio	8.86
Short Interest	12.81M
52W High	4.55 -80.86%
52W Low	0.83 5.06%
Volatility	9.76% 9.08%
ATR (14)	0.13
RSI (14)	27.57
Beta	1.47
Rel Volume	0.01
Avg Volume	1.45M
Volume	621

Perf Week	-34.44%
Perf Month	-30.79%
Perf Quarter	-48.40%
Perf Half Y	-68.97%
Perf YTD	-68.97%
Perf Year	-80.40%
Perf 3Y	-39.02%
Perf 5Y	-85.02%
Perf 10Y	-99.76%
Recom	2.00
Target Price	6.21
Prev Close	0.87
Price	0.87
Change	-0.29%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-26	Downgrade	Craig Hallum	Buy → Hold	$2
Jun-01-26	Downgrade	TD Cowen	Buy → Hold
Jun-01-26	Downgrade	H.C. Wainwright	Buy → Neutral
Jan-05-26	Initiated	Noble Capital Markets	Outperform	$12
Jul-08-25	Initiated	Ladenburg Thalmann	Buy	$19
Jun-24-25	Initiated	Jefferies	Hold	$3.50
Sep-06-24	Initiated	Craig Hallum	Buy	$8
Jan-05-22	Initiated	William Blair	Outperform
Dec-08-21	Initiated	Robert W. Baird	Outperform	$19
Aug-09-21	Resumed	Maxim Group	Buy	$30 → $20
Oct-22-20	Initiated	H.C. Wainwright	Buy	$27
Oct-08-20	Initiated	Piper Sandler	Overweight	$25

Show Previous Ratings

Jul-15-26 10:54AM	Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital (InvestorsHub) -32.11%
08:00AM	Cardiff Oncology Announces $10 Million Registered Direct Offering (GlobeNewswire)
Jun-02-26 09:06AM	Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting (GlobeNewswire)
Jun-01-26 04:01PM	Cardiff Oncology to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) -22.11%
May-21-26 05:00PM	Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC (GlobeNewswire)
04:22PM	Loading…
May-14-26 04:22PM	Cardiff Oncology: Q1 Earnings Snapshot (Associated Press)
04:10PM	Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update (GlobeNewswire)
Apr-28-26 04:01PM	Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-27-26 07:00AM	Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib's Promising Single-Agent Activity (GlobeNewswire)
Apr-21-26 10:00AM	Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026 (GlobeNewswire) -7.30%
Apr-17-26 04:01PM	Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting (GlobeNewswire) +6.51%
Apr-09-26 04:01PM	Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth (GlobeNewswire) +7.05% -5.39%
Mar-27-26 08:05AM	These 16 stocks are a short seller's dream - likely losers no matter what the market does (MarketWatch) -7.19%
Mar-20-26 07:00AM	Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer (GlobeNewswire)
Mar-19-26 07:00AM	Cardiff Oncology to Present Preclinical Data with Highly Specific PLK1 Inhibitor Onvansertib at the 2026 AACR Annual Meeting (GlobeNewswire)
04:01PM	Loading…
Feb-26-26 04:01PM	Cardiff Oncology to Participate in Three Upcoming Investor Conferences (GlobeNewswire)
04:32AM	Cardiff Oncology Spotlights Onvansertib Data at Oppenheimer: 72% ORR in RAS-Mutant mCRC (MarketBeat)
Feb-24-26 05:26PM	Cardiff Oncology: Q4 Earnings Snapshot (Associated Press Finance) +8.97% +12.35%
04:30PM	Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update (GlobeNewswire)
Feb-19-26 07:00AM	Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-28-26 06:23AM	Cardiff Oncology Stock Plunges After Sudden Leadership Change, Narrowed Trial Focus (Benzinga) -19.00%
Jan-27-26 10:54AM	Cardiff Oncology Taps Interim CEO, Picks 30mg Onvansertib Regimen for 2026 Registrational mCRC Study (MarketBeat) -31.97%
07:05AM	Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC (GlobeNewswire)
07:00AM	Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development (GlobeNewswire)
Dec-08-25 04:05PM	Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 (GlobeNewswire) +10.90%
07:00AM	Cardiff Oncology to Present at Sidoti's Year-End Virtual Investor Conference (GlobeNewswire)
Nov-24-25 07:00AM	Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-06-25 04:33PM	Cardiff Oncology: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Nov-04-25 04:01PM	Cardiff Oncology to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
04:05PM	Loading…
Oct-02-25 04:05PM	Cardiff Oncology to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Aug-28-25 04:05PM	Cardiff Oncology to Participate in Three Upcoming Investor Conferences (GlobeNewswire)
Jul-29-25 05:25PM	Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -11.26% -24.77%
04:23PM	Cardiff Oncology: Q2 Earnings Snapshot (Associated Press Finance)
04:07PM	Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004) (GlobeNewswire)
04:05PM	Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update (GlobeNewswire)
Jun-19-25 09:25AM	Cardiff Oncology to share CRDF-004 trial data on July 29 (TipRanks)
09:25AM	Cardiff selloff brings attractive entry point, says H.C. Wainwright (TipRanks)
Jun-17-25 04:05PM	Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC (GlobeNewswire) -18.38%
Jun-02-25 04:05PM	Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025 (GlobeNewswire)
May-14-25 12:00PM	Cardiff Oncology (CRDF) Upgraded to Buy: Here's What You Should Know (Zacks)
May-08-25 05:25PM	Cardiff Oncology (CRDF) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +5.62%
04:05PM	Cardiff Oncology Reports First Quarter 2025 Results and Provides Business Update (GlobeNewswire)
May-02-25 03:35AM	Cardiff Oncology: Expecting Massive Updates In Colon Cancer Soon (Seeking Alpha)
Apr-28-25 10:00AM	ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
Apr-24-25 10:01AM	Cardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-23-25 04:05PM	Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naive Patients (GlobeNewswire)
04:05PM	Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Na ve Patients (GlobeNewswire)
Apr-15-25 04:10PM	Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.38%
04:05PM	Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer (GlobeNewswire)
Mar-26-25 03:57PM	Is Cardiff Oncology, Inc. (CRDF) The Hot Biotech Stock Under $5? (InsiderMonkey) -6.84%
Mar-08-25 07:33AM	Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge (PR Newswire)
Feb-27-25 04:05PM	Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update (GlobeNewswire) -8.97%
Feb-26-25 08:12AM	Cardiff Oncology Inc (CRDF) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com) +5.44%
Feb-24-25 04:05PM	Cardiff Oncology to Present at Upcoming Investor Conferences (GlobeNewswire) -7.24%
Feb-20-25 04:05PM	Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update (GlobeNewswire)
Dec-26-24 09:00AM	Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook (GlobeNewswire) +10.71%
Dec-20-24 12:52PM	Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses (PR Newswire) -5.12%
Dec-18-24 11:12AM	Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments (PR Newswire) -16.07%
Dec-14-24 06:50AM	Cardiff Oncology price target raised to $10 from $7 at Piper Sandler (TipRanks)
Dec-11-24 07:19AM	Cardiff Oncology Reports Promising Phase 2 Trial Results (TipRanks)
Dec-10-24 07:20AM	Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering (GlobeNewswire) +54.92%
06:00AM	Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial (GlobeNewswire)
Nov-19-24 08:00AM	Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC (GlobeNewswire)
Nov-07-24 04:05PM	Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update (GlobeNewswire) +7.35% -24.69%
Oct-30-24 04:30PM	Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC (GlobeNewswire)
Aug-08-24 04:05PM	Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update (GlobeNewswire) +11.74%
Aug-01-24 04:05PM	Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update (GlobeNewswire)
May-29-24 04:05PM	Cardiff Oncology to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-13-24 04:05PM	Cardiff Oncology to Present at Upcoming Investor Conferences in May (GlobeNewswire)
May-09-24 12:15PM	Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 (PR Newswire) +5.63%
May-07-24 06:00AM	The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028 (InvestorPlace)
May-02-24 09:54PM	CRDF Stock Earnings: Cardiff Oncology Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +5.91% -21.43%
05:45PM	Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update (GlobeNewswire)
Apr-25-24 04:05PM	Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update (GlobeNewswire)
Apr-08-24 04:05PM	Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study (GlobeNewswire)
Apr-01-24 08:50AM	Cardiff Oncology (CRDF) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks) +7.30%
Mar-21-24 07:55AM	Cardiff (CRDF) Stock Rallies 194% in a Month: Here's Why (Zacks)
Mar-14-24 08:50AM	Here's Why Momentum in Cardiff Oncology (CRDF) Should Keep going (Zacks)
08:08AM	Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last? (Zacks)
Mar-06-24 04:05PM	Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024 (GlobeNewswire) +6.58% -9.77%
12:00PM	What Makes Cardiff Oncology (CRDF) a Strong Momentum Stock: Buy Now? (Zacks)
Mar-01-24 10:12AM	Cardiff Oncology Inc (CRDF) Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com) +64.87%
Feb-29-24 07:40PM	Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (GlobeNewswire)
04:06PM	Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC (GlobeNewswire)
04:05PM	Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004) (GlobeNewswire)
Feb-26-24 08:00AM	Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-22-24 08:00AM	Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update (GlobeNewswire)
Jan-17-24 10:30AM	Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research (PR Newswire) -9.82%
Nov-20-23 04:05PM	Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference (PR Newswire)
Nov-02-23 04:05PM	Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update (PR Newswire) +8.57%
Oct-26-23 04:05PM	Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update (PR Newswire)
Oct-23-23 08:45AM	Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing (PR Newswire) -10.27%
Oct-11-23 09:35AM	Cardiff Oncology (CRDF) Loses -29.75% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Sep-26-23 04:05PM	Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy (PR Newswire)
Sep-05-23 08:00AM	Cardiff Oncology to Present at Upcoming Investor Conferences in September (PR Newswire)
Aug-09-23 04:05PM	Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update (PR Newswire) -12.39% +8.38%
Aug-07-23 04:05PM	Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship (PR Newswire) -8.19% +38.85%

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. Its clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.

PresidentDr. Mani Mohindru Ph.D.

M.D.Dr. Roger Sidhu FRCPC

M.B.A.Mr. Josh Muntner BFA

M.D.Dr. Ajay Aggarwal M.B.A.

Chief Accounting OfficerMs. Brigitte Lindsay

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PACE GARY W	Director	Jul 14 '26	Buy	1.46	687,285	1,000,000	2,043,661	Jul 16 04:03 PM
Mohindru Mani	Chief Executive Officer	Jul 14 '26	Buy	1.46	34,364	50,000	59,067	Jul 16 04:01 PM
Mohindru Mani	Chief Executive Officer	Jun 18 '26	Buy	1.21	24,703	29,891	24,703	Jun 22 09:00 AM
PACE GARY W	Director	Jun 18 '26	Buy	1.22	30,000	36,600	1,356,376	Jun 22 09:00 AM
PACE GARY W	Director	Jul 30 '25	Buy	2.45	275,000	673,750	1,330,676	Jul 31 04:05 PM
PACE GARY W	Director	Jul 30 '25	Buy	2.45	15,000	36,750	1,345,676	Jul 31 04:05 PM

VIRC Virco Manufacturing Corp daily Stock Chart

Peers: HOFT FLXS HBB LCUT BSET COOK KEQU LOVE ETD LZB

| Held by: VTI AVUV VXF DFAT DFSV DFMC DES BSVO IWC DFAS

Index	-
Market Cap	95.32M
Enterprise Value	130.35M
Income	-0.94M
Sales	196.59M
Book/sh	6.51
Cash/sh	0.24
Dividend Est.	-
Dividend TTM	0.10 (1.65%)
Dividend Ex-Date	Jun 18, 2026
Dividend Gr. 3/5Y	- -
Payout	61.43%
Employees	731
IPO	Mar 08, 1977

P/E	-
Forward P/E	18.36
PEG	0.37
P/S	0.48
P/B	0.93
P/C	25.55
P/FCF	20.15
EV/EBITDA	21.13
EV/Sales	0.66
Quick Ratio	0.90
Current Ratio	2.71
Debt/Eq	0.38
LT Debt/Eq	0.31
Option/Short	Yes / Yes

EPS (ttm)	-0.06
EPS next Y	0.33
EPS next Q	0.07
EPS this Y	-93.75%
EPS next Y	3200.00%
EPS next 5Y	49.07%
EPS past 3/5Y	-45.79% -
Sales past 3/5Y	-4.75% 5.50%
EPS Y/Y TTM	-104.75%
Sales Y/Y TTM	-22.38%
EPS Q/Q	-480.39%
Sales Q/Q	-9.07%
Earnings	Jun 03 BMO
EPS/Sales Surpr.	-1900.00% 12.84%

Insider Own	16.22%
Insider Trans	1.81%
Inst Own	48.19%
Inst Trans	-3.22%
ROA	-0.52%
ROE	-0.90%
ROIC	-0.70%
Gross Margin	39.43%
Oper. Margin	0.05%
Profit Margin	-0.48%
SMA20	-2.70%
SMA50	-0.83%
SMA200	-6.13%
Trades

Shs Outstand	15.73M
Shs Float	13.18M
Short Float	2.31%
Short Ratio	4.41
Short Interest	0.30M
52W High	9.09 -33.30%
52W Low	5.16 17.56%
Volatility	2.81% 4.31%
ATR (14)	0.24
RSI (14)	46.85
Beta	0.22
Rel Volume	0.00
Avg Volume	69.09K
Volume	0

Perf Week	-0.66%
Perf Month	-3.81%
Perf Quarter	-0.49%
Perf Half Y	-4.11%
Perf YTD	-5.16%
Perf Year	-23.68%
Perf 3Y	51.12%
Perf 5Y	76.68%
Perf 10Y	24.95%
Recom	3.00
Target Price	6.50
Prev Close	6.06
Price	6.06
Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-21-17	Resumed	Wedbush	Outperform	$5 → $6
Apr-20-09	Reiterated	Wedbush Morgan	Hold	$2.75 → $3
Dec-15-08	Reiterated	Wedbush Morgan	Hold	$5 → $2.75
Sep-12-08	Reiterated	Wedbush Morgan	Hold	$5.75 → $5
Dec-11-07	Reiterated	Wedbush Morgan	Hold	$8 → $7.50
Sep-12-07	Reiterated	Wedbush Morgan	Hold	$7.50 → $8

Jun-03-26 08:30AM	Virco Reports $2.8 Million First Quarter Loss as Demand for School Furniture Slows (GlobeNewswire) -9.48%
Apr-08-26 08:30AM	Virco Reports Full Year Net Income of $2.6 Million on Revenue of $199.7 Million (GlobeNewswire) -5.33%
Dec-08-25 08:30AM	Virco Reports Loss of $1.3 Million in Third Quarter as Cyclical Decline Begins to Slow (GlobeNewswire) -6.05%
Sep-05-25 09:45AM	Virco Manufacturing Corporation (VIRC) Q2 Earnings and Revenues Miss Estimates (Zacks)
08:30AM	Virco Reports Solid Operating and Net Income for Second Quarter and First Six Months, Despite Significant Reduction in Revenue (GlobeNewswire)
05:20PM	Loading…
Aug-18-25 05:20PM	Flexsteel Industries (FLXS) Beats Q4 Earnings and Revenue Estimates (Zacks)
Aug-11-25 07:00PM	iHeartMedia (IHRT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-25-25 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
Jul-09-25 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
Jun-27-25 04:27AM	Zacks Industry Outlook Highlights Sleep Number and Virco (Zacks)
Jun-26-25 10:59AM	2 Furniture Stocks to Buy From Promising Industry Landscape (Zacks)
Jun-23-25 09:40AM	Are Investors Undervaluing Virco Manufacturing (VIRC) Right Now? (Zacks) +8.19%
09:04AM	Best Value Stocks to Buy for June 23rd (Zacks)
04:52AM	Best Income Stocks to Buy for June 23rd (Zacks)
Jun-06-25 09:45AM	Virco Manufacturing Corporation (VIRC) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
08:30AM	Loading…
08:30AM	Virco Reports $700,000 First Quarter Profit as Demand for School Furniture Slows (GlobeNewswire)
May-01-25 05:42PM	Virco: Despite Possible Positives, Still Not Cheap Enough To Warrant A Buy (Seeking Alpha)
Apr-15-25 12:28PM	Virco Q4 Loss Wider-Than-Expected, Sales Miss Estimates, Stock Down (Zacks)
Apr-14-25 08:30AM	Virco Marks 75th Anniversary with Strong Earnings Results, Positive Cash Flow, Higher Shareholder Returns, and Strategic Re-Investment (GlobeNewswire)
Mar-26-25 05:30PM	MillerKnoll (MLKN) Matches Q3 Earnings Estimates (Zacks)
Jan-21-25 08:30AM	Virco Adopts New Share Repurchase Program (GlobeNewswire) +12.94%
Dec-09-24 09:45AM	Virco Manufacturing Corporation (VIRC) Lags Q3 Earnings and Revenue Estimates (Zacks) -17.72%
08:30AM	Virco Reports Third Quarter Results: Robust Balance Sheet and Strengthening Cash Flows as School Furniture Market Returns to pre-Pandemic Seasonal Patterns (GlobeNewswire)
Oct-30-24 04:37PM	Is Virco Mfg. Corporation (VIRC) The Best Furniture Stock To Invest In According To Analysts? (Insider Monkey)
Sep-09-24 09:50AM	Virco Manufacturing Corporation (VIRC) Surpasses Q2 Earnings Estimates (Zacks) -9.25%
08:30AM	Virco Reports Improved Financial Position Following Record Second Quarter and First Half Results (GlobeNewswire)
Aug-01-24 09:40AM	Is Virco Manufacturing (VIRC) Stock Undervalued Right Now? (Zacks)
08:50AM	Here's Why Momentum in Virco Manufacturing (VIRC) Should Keep going (Zacks)
Jul-17-24 06:31PM	Is Virco Mfg. Corporation (VIRC) the Best Small-Cap Stock to Buy Right Now? (Insider Monkey)
Jul-16-24 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
08:50AM	Loading…
08:50AM	Virco Manufacturing (VIRC) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Jul-02-24 07:37PM	Virco Manufacturing (VIRC) and BRF (BRFS) Are Aggressive Growth Stocks (Zacks)
Jun-12-24 09:40AM	Are Investors Undervaluing Virco Manufacturing (VIRC) Right Now? (Zacks)
08:50AM	Recent Price Trend in Virco Manufacturing (VIRC) is Your Friend, Here's Why (Zacks)
Jun-10-24 08:42AM	Virco's (VIRC) Shares Gain on Q1 Earnings & Net Sales Beat (Zacks) +18.88%
Jun-07-24 12:52PM	VIRC Stock Earnings: Virco Mfg Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +21.45%
09:50AM	Virco Manufacturing Corporation (VIRC) Beats Q1 Earnings and Revenue Estimates (Zacks)
08:30AM	Virco Reports 33.7% Increase in First Quarter Revenue; Net Income of $2.1 million; Declares Regular Quarterly Dividend (GlobeNewswire)
May-30-24 03:23PM	Sixfold Fortunes: 3 Bargain Stocks Set for 6X Gains by 2030 (InvestorPlace)
Apr-15-24 10:48AM	Virco (VIRC) Reports Loss for Q4 Despite Higher Net Revenues (Zacks) -14.71%
Apr-12-24 10:10AM	Virco Manufacturing Corporation (VIRC) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +6.54%
09:00AM	Virco Reports Full Year Revenue Increased 16.5% to $269.1 million, delivering 32.4% growth in Net Income (GlobeNewswire)
Apr-01-24 08:30AM	Virco Issues Updated Investor Presentation (GlobeNewswire)
Feb-27-24 08:00AM	Virco Announces First Quarter Cash Dividend (GlobeNewswire) +5.42%
Jan-24-24 09:15AM	Virco Manufacturing Corporation (VIRC) Hits Fresh High: Is There Still Room to Run? (Zacks)
Jan-23-24 08:50AM	Virco Manufacturing Corporation (VIRC) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Jan-18-24 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
Jan-05-24 09:15AM	Virco Manufacturing Corporation (VIRC) Hit a 52 Week High, Can the Run Continue? (Zacks)
Jan-02-24 08:50AM	Here's Why Momentum in Virco Manufacturing Corporation (VIRC) Should Keep going (Zacks) -6.57%
Dec-28-23 12:00PM	Are You Looking for a Top Momentum Pick? Why Virco Manufacturing Corporation (VIRC) is a Great Choice (Zacks)
Dec-21-23 09:40AM	Are Investors Undervaluing Virco Manufacturing (VIRC) Right Now? (Zacks)
Dec-18-23 09:25AM	Virco Manufacturing Corporation (VIRC) Soars to 52-Week High, Time to Cash Out? (Zacks)
Dec-14-23 08:50AM	Here's What Could Help Virco Manufacturing Corporation (VIRC) Maintain Its Recent Price Strength (Zacks)
Dec-09-23 07:28PM	Virco Manufacturing Corp Reports Record Q3 and YTD Financials; Initiates Dividend and Share Buyback (GuruFocus.com)
Dec-08-23 08:10AM	Virco Manufacturing Corporation (VIRC) Surpasses Q3 Earnings and Revenue Estimates (Zacks) +21.40%
07:00AM	Virco Reports Record 3rd Quarter and YTD Results (GlobeNewswire)
Oct-17-23 08:50AM	What Makes Virco Manufacturing Corporation (VIRC) a Good Fit for 'Trend Investing' (Zacks)
Sep-29-23 08:50AM	Virco Manufacturing Corporation (VIRC) is on the Move, Here's Why the Trend Could be Sustainable (Zacks) +9.52%
Sep-13-23 10:00AM	Best Momentum Stock to Buy for September 13th (Zacks)
08:50AM	Virco Manufacturing Corporation (VIRC) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
08:47AM	Best Value Stocks to Buy for September 13th (Zacks)
Sep-11-23 10:15AM	Virco Manufacturing Corporation (VIRC) Surpasses Q2 Earnings and Revenue Estimates (Zacks) +9.48%
08:30AM	Virco Operating Income Nearly Doubles as Second Quarter Revenue Jumps 30% (GlobeNewswire)
Sep-07-23 09:40AM	Toro (TTC) Q3 Earnings and Revenues Lag Estimates (Zacks)
Aug-22-23 08:50AM	Sphere Entertainment (SPHR) Beats Q4 Earnings Estimates (Zacks)
Jul-31-23 06:05AM	Investors in Virco Mfg (NASDAQ:VIRC) have seen decent returns of 100% over the past three years (Simply Wall St.)
Jul-25-23 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
Jul-24-23 08:10AM	Best Value Stocks to Buy for July 24th (Zacks)
07:12AM	Daily Vickers Top Buyers & Sellers for 07/24/2023 (Argus Research)
Jul-17-23 09:40AM	Is American Woodmark (AMWD) Stock Undervalued Right Now? (Zacks)
Jul-14-23 06:38AM	Virco Mfg. Corporation's (NASDAQ:VIRC) Share Price Is Matching Sentiment Around Its Revenues (Simply Wall St.)
Jun-30-23 09:40AM	Are Investors Undervaluing Virco Manufacturing (VIRC) Right Now? (Zacks)
Jun-14-23 09:40AM	Should Value Investors Buy Virco Manufacturing (VIRC) Stock? (Zacks)
Jun-12-23 08:45AM	Virco Manufacturing Corporation (VIRC) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +8.63%
07:30AM	Virco Reports 8.7% Increase in First Quarter Revenue and 16.4% Increase in Shipments + Backlog (GlobeNewswire)
May-21-23 10:46AM	Should You Investigate Virco Mfg. Corporation (NASDAQ:VIRC) At US$3.97? (Simply Wall St.)
Apr-30-23 08:05AM	Virco Mfg. Corporation's (NASDAQ:VIRC) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? (Simply Wall St.)
Apr-28-23 10:45AM	Virco Manufacturing Corporation (VIRC) Q4 Earnings Top Estimates (Zacks)
09:30AM	Virco Reports Full Year Revenue Increased 25% to $231.1 Million, Delivering Operating Income of $10.8 Million (GlobeNewswire)
Mar-26-23 08:16AM	Virco Mfg (NASDAQ:VIRC) Is Doing The Right Things To Multiply Its Share Price (Simply Wall St.)
Feb-13-23 12:15PM	Those who invested in Virco Mfg (NASDAQ:VIRC) a year ago are up 58% (Simply Wall St.)
Jan-26-23 09:40AM	Are Investors Undervaluing Virco Manufacturing (VIRC) Right Now? (Zacks)
Jan-16-23 09:40AM	Is Virco Manufacturing (VIRC) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
09:40AM	Are Investors Undervaluing Flexsteel Industries (FLXS) Right Now? (Zacks)
Jan-13-23 05:00AM	Zacks.com featured highlights Expro Group Holdings, Banco Bilbao Viscaya Argentaria and Virco Manufacturing (Zacks)
Jan-12-23 07:51AM	3 Top Breakout Stocks Worth a Buy in 2023 (Zacks)
Dec-28-22 09:40AM	Is Virco Manufacturing (VIRC) Stock Undervalued Right Now? (Zacks)
Dec-27-22 07:42AM	Best Value Stocks to Buy for December 27th (Zacks)
Dec-19-22 09:40AM	Is Flexsteel Industries (FLXS) Stock Undervalued Right Now? (Zacks) +5.25%
Dec-16-22 09:40AM	Is TAL Education Group (TAL) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks) -6.10%
08:59AM	Virco Mfg Third Quarter 2023 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Dec-14-22 12:00PM	What Makes Virco Manufacturing Corporation (VIRC) a New Buy Stock (Zacks)
Dec-12-22 08:45AM	Virco Manufacturing Corporation (VIRC) Q3 Earnings Beat Estimates (Zacks) +8.40%
07:30AM	Virco Reports Third Quarter Revenue Increased 35%, Driving Improved Financial Performance Across Multiple Metrics (GlobeNewswire)
Nov-18-22 07:45AM	New Strong Buy Stocks for November 18th (Zacks)
Nov-08-22 09:40AM	Is TAL Education Group (TAL) Outperforming Other Consumer Discretionary Stocks This Year? (Zacks)
Oct-17-22 06:46AM	These Return Metrics Don't Make Virco Mfg (NASDAQ:VIRC) Look Too Strong (Simply Wall St.)
Oct-13-22 09:40AM	Is New Oriental Education & Technology Group (EDU) Stock Outpacing Its Consumer Discretionary Peers This Year? (Zacks)
Sep-27-22 09:40AM	Is Trip.com Group Limited (TCOM) Outperforming Other Consumer Discretionary Stocks This Year? (Zacks)
07:34AM	Zacks Industry Outlook Highlights WillScot Mobile Mini, La-Z-Boy and Virco (Zacks)

Virco Manufacturing Corp. engages in the design, production and distribution of furniture. Its products include mobile tables, mobile storage equipment, desks, computer furniture, chairs, foldable chairs and foldable tables. The company was founded in February 1950 and is headquartered in Torrance, CA.

Chairman of the Board & CEOMr. Robert A. Virtue

President & DirectorMr. Douglas A. Virtue

Senior VP of FinanceMs. Bassey Yau

VP of Sales & DirectorMs. Kathy Virtue Young

Senior VP & COOMr. J. Scott Bell

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
VIRTUE DOUGLAS A	Executive Vice President	Jul 15 '26	Buy	6.00	5,140	30,838	893,808	Jul 16 04:32 PM
VIRTUE DOUGLAS A	Executive Vice President	Jul 16 '26	Buy	6.00	600	3,600	894,408	Jul 16 04:32 PM
VIRTUE DOUGLAS A	Executive Vice President	Jul 08 '26	Buy	6.00	8,083	48,474	888,663	Jul 09 04:36 PM
VIRTUE DOUGLAS A	Executive Vice President	Jul 09 '26	Buy	6.00	5	30	888,668	Jul 09 04:36 PM
VIRTUE DOUGLAS A	Executive Vice President	Jun 29 '26	Buy	6.00	1,400	8,400	880,580	Jun 30 04:50 PM
VIRTUE ROBERT A	CEO	Jun 11 '26	Buy	6.22	4,300	26,758	506,124	Jun 15 01:29 PM
VIRTUE DOUGLAS A	Executive Vice President	Jun 09 '26	Buy	6.00	1,314	7,884	879,180	Jun 11 03:23 PM
VIRTUE DOUGLAS A	Executive Vice President	Apr 15 '26	Buy	6.09	11,678	71,119	877,866	Apr 15 05:34 PM
VIRTUE DOUGLAS A	Executive Vice President	Apr 14 '26	Buy	6.07	4,349	26,398	866,188	Apr 15 05:34 PM
Lind Robert R	Director	Apr 15 '26	Buy	6.07	500	3,035	119,890	Apr 15 03:03 PM
VIRTUE ROBERT A	CEO	Apr 14 '26	Buy	6.22	2,700	16,794	501,824	Apr 14 02:57 PM
RICHARDSON BRADLEY C	Director	Apr 10 '26	Buy	5.59	1,600	8,944	39,354	Apr 13 04:29 PM
RICHARDSON BRADLEY C	Director	Apr 13 '26	Buy	5.63	400	2,252	39,754	Apr 13 04:29 PM
VIRTUE ROBERT A	CEO	Apr 10 '26	Buy	5.52	3,300	18,216	499,124	Apr 13 04:28 PM
VIRTUE ROBERT A	CEO	Jan 13 '26	Buy	6.32	2,500	15,800	495,824	Jan 13 05:29 PM
RICHARDSON BRADLEY C	Director	Jan 07 '26	Buy	6.50	2,000	13,009	37,754	Jan 07 04:19 PM
VIRTUE DOUGLAS A	Executive Vice President	Oct 17 '25	Buy	7.34	13,022	95,581	861,839	Oct 17 05:09 PM
VIRTUE ROBERT A	CEO	Oct 16 '25	Buy	6.96	5,000	34,800	493,324	Oct 16 04:49 PM

ANIX Anixa Biosciences Inc daily Stock Chart

Peers: ATYR COYA CYPH INO LONA NRXS CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC

Index	-
Market Cap	112.96M
Enterprise Value	98.20M
Income	-10.03M
Sales	0.00M
Book/sh	0.43
Cash/sh	0.40
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4
IPO	Oct 07, 1983

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	7.78
P/C	8.25
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	9.79
Current Ratio	9.79
Debt/Eq	0.01
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-0.30
EPS next Y	-0.33
EPS next Q	-0.08
EPS this Y	6.35%
EPS next Y	-3.17%
EPS next 5Y	-1.16%
EPS past 3/5Y	9.05% 5.67%
Sales past 3/5Y	- -
EPS Y/Y TTM	19.64%
Sales Y/Y TTM	-
EPS Q/Q	13.51%
Sales Q/Q	-
Earnings	Jun 05
EPS/Sales Surpr.	14.71% -

Insider Own	5.45%
Insider Trans	2.30%
Inst Own	14.97%
Inst Trans	-2.98%
ROA	-63.02%
ROE	-65.70%
ROIC	-68.66%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	11.02%
SMA50	17.71%
SMA200	1.11%
Trades

Shs Outstand	33.92M
Shs Float	32.17M
Short Float	2.75%
Short Ratio	4.73
Short Interest	0.89M
52W High	5.46 -39.16%
52W Low	2.32 43.10%
Volatility	9.14% 9.34%
ATR (14)	0.25
RSI (14)	60.58
Beta	0.58
Rel Volume	0.00
Avg Volume	187.41K
Volume	0

Perf Week	3.11%
Perf Month	33.87%
Perf Quarter	13.31%
Perf Half Y	1.22%
Perf YTD	6.41%
Perf Year	-1.19%
Perf 3Y	-8.79%
Perf 5Y	-16.58%
Perf 10Y	-1.35%
Recom	1.00
Target Price	10.00
Prev Close	3.32
Price	3.32
Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-21-25	Initiated	Maxim Group	Buy	$10
Dec-23-22	Initiated	Chardan Capital Markets	Buy	$8
Apr-12-21	Initiated	H.C. Wainwright	Buy	$11

Jul-14-26 08:33AM	Anixa Biosciences Expands Global Patent Portfolio with Australian Patent Acceptance for Breast Cancer Vaccine Technology (PR Newswire)
Jul-06-26 08:30AM	Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date (PR Newswire) -6.73%
Jun-30-26 06:35AM	Anixa Biosciences secures Korean patent for breast cancer vaccine (Pharmaceutical Business Review)
Jun-29-26 08:45AM	Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040 (PR Newswire)
Jun-26-26 09:10AM	Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium (PR Newswire) +6.49%
09:05AM	Loading…
Jun-11-26 09:05AM	Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium (PR Newswire) +5.53%
Jun-01-26 09:00AM	Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance (PR Newswire)
May-11-26 08:55AM	Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy (PR Newswire)
May-01-26 09:15AM	Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV (PR Newswire)
Apr-29-26 09:10AM	Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology (PR Newswire)
Apr-22-26 08:45AM	Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting (PR Newswire) +9.03%
Apr-09-26 09:05AM	Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026 (PR Newswire)
Apr-07-26 08:55AM	Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026 (PR Newswire)
Apr-06-26 09:10AM	Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs (PR Newswire)
Apr-01-26 08:50AM	Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing (PR Newswire) +5.43%
09:05AM	Loading…
Mar-30-26 09:05AM	Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer (PR Newswire)
Mar-12-26 10:38AM	Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast (PR Newswire)
Mar-09-26 08:30AM	Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology (PR Newswire)
Mar-02-26 09:10AM	Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress (PR Newswire)
Feb-23-26 08:55AM	Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat (PR Newswire)
Feb-10-26 03:50PM	Anixa Biosciences CEO Calls 2026 Pivotal as Breast Cancer Vaccine, Ovarian CAR-T Advance (MarketBeat)
Feb-09-26 08:00AM	Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation (PR Newswire)
07:31AM	EXCLUSIVE: Anixa Biosciences' Ovarian Cancer Drug Candidate Shows Longer Survival With No Major Safety Issues (Benzinga)
Feb-02-26 09:00AM	Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization (PR Newswire)
Jan-27-26 08:30AM	Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology (PR Newswire)
Dec-15-25 08:45AM	Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic (PR Newswire) -8.94%
Dec-10-25 09:00AM	Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 (PR Newswire)
Nov-17-25 08:15AM	Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization (PR Newswire)
Nov-12-25 09:00AM	Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s (PR Newswire)
Nov-10-25 10:30AM	Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025 (PR Newswire)
09:40AM	Loading…
Nov-05-25 09:40AM	Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year? (Zacks)
08:55AM	Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic (PR Newswire)
Oct-23-25 08:45AM	Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference (PR Newswire)
Oct-20-25 08:25AM	Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology (PR Newswire)
Oct-17-25 12:00PM	Are You Looking for a Top Momentum Pick? Why ANIXA BIOSCIENCES INC (ANIX) is a Great Choice (Zacks) -6.82%
Oct-08-25 10:58AM	Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034 (PR Newswire) +8.03%
Oct-07-25 08:30AM	Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial (PR Newswire) +26.46%
Oct-02-25 09:40AM	Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year? (Zacks)
Sep-22-25 08:05AM	Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium (PR Newswire) +5.76%
Sep-16-25 12:29PM	Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals (PR Newswire)
09:40AM	Is Solventum Corporation (SOLV) Stock Outpacing Its Medical Peers This Year? (Zacks)
Sep-09-25 06:45PM	3 Under-the-Radar Biotechs Under $5 That Could Soar 200% (MarketBeat)
Sep-08-25 08:00AM	Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival (PR Newswire)
Sep-02-25 08:54AM	Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference (PR Newswire)
Aug-25-25 09:13AM	Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference (PR Newswire)
Aug-20-25 08:37AM	Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology (PR Newswire)
Aug-18-25 09:00AM	Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Aug-12-25 08:05AM	Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology (PR Newswire)
Aug-08-25 09:15AM	Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference (PR Newswire)
Aug-04-25 08:45AM	Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial (PR Newswire) +8.31%
Jul-30-25 08:15AM	Anixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology (PR Newswire)
Jul-25-25 09:40AM	Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jul-24-25 08:00AM	Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s (PR Newswire)
Jul-09-25 09:40AM	Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year? (Zacks)
08:00AM	Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology (PR Newswire)
Jun-26-25 12:00PM	ANIXA BIOSCIENCES INC (ANIX) is a Great Momentum Stock: Should You Buy? (Zacks)
Jun-23-25 09:40AM	Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year? (Zacks)
08:00AM	Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Jun-20-25 07:30AM	Anixa Biosciences to Host an Investor Webcast on June 26, 2025 (PR Newswire)
Jun-12-25 10:00AM	As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry (PR Newswire) +5.42%
Jun-10-25 12:00PM	What Makes ANIXA BIOSCIENCES INC (ANIX) a Strong Momentum Stock: Buy Now? (Zacks)
07:00AM	Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage (PR Newswire)
Jun-09-25 08:00AM	Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025 (PR Newswire) +23.19%
Jun-05-25 12:00PM	All You Need to Know About Anixa Biosciences (ANIX) Rating Upgrade to Buy (Zacks)
09:40AM	Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year? (Zacks)
Jun-03-25 07:25AM	Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview (PR Newswire)
Jun-02-25 07:00AM	Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine (PR Newswire) +12.45%
May-19-25 08:00AM	Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones (PR Newswire)
May-12-25 08:00AM	Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
Apr-30-25 08:00AM	Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th (PR Newswire)
Apr-14-25 08:00AM	Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio (PR Newswire)
Apr-11-25 09:40AM	Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year? (Zacks)
Apr-10-25 09:58AM	ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up (Zacks)
Apr-09-25 08:00AM	Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology (PR Newswire) +13.03%
07:45AM	EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent (Benzinga)
Apr-01-25 08:00AM	Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th (PR Newswire)
Mar-25-25 08:00AM	Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines (PR Newswire)
07:51AM	EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines (Benzinga)
Mar-24-25 08:00AM	Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine (PR Newswire)
07:46AM	EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine (Benzinga)
Mar-17-25 08:00AM	Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th (PR Newswire)
Mar-10-25 08:30AM	Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties (PR Newswire) -7.39%
Mar-03-25 08:00AM	Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th (PR Newswire) -9.84%
Feb-26-25 08:00AM	Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Feb-25-25 07:30AM	Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' 'America Reports' (PR Newswire)
Feb-24-25 08:00AM	Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer (PR Newswire) -6.49%
Feb-18-25 08:00AM	Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Feb-14-25 07:00AM	Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview (PR Newswire)
Feb-11-25 08:30AM	Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum (PR Newswire)
Feb-04-25 08:30AM	Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention (PR Newswire) +6.07%
Jan-21-25 08:30AM	Anixa Biosciences CEO Provides Letter to Shareholders (PR Newswire) +16.60%
Dec-06-24 08:30AM	iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024 (ACCESS Newswire)
Dec-04-24 08:30AM	Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 (PR Newswire)
Nov-22-24 08:15AM	Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset (PR Newswire)
Nov-18-24 08:20AM	Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Nov-08-24 01:17PM	Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire)
Nov-06-24 08:30AM	Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire)
Oct-31-24 08:15AM	Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024 (PR Newswire)
Oct-28-24 08:30AM	Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire) +22.15%
Oct-16-24 05:42AM	Anixa Biosciences administers second CAR-T dose in ovarian cancer trial (Clinical Trials Arena)

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The Other segment refers to its legacy operations, including patent licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

CEODr. Amit Kumar Ph.D.

MBAMr. Michael J. Catelani CPA

Chief Development Officer & Chair Breast Cancer Clinical Advisory BoardDr. Pamela D. Garzone Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Titterton Lewis H jr	Director	Jul 15 '26	Buy	3.28	2,797	9,174	974,967	Jul 16 09:00 AM
KUMAR AMIT	Chief Executive Officer	Jul 10 '26	Buy	3.04	5,000	15,200	635,812	Jul 13 08:59 AM
Titterton Lewis H jr	Director	Jun 16 '26	Buy	2.64	2,836	7,487	972,170	Jun 17 11:21 AM
KUMAR AMIT	Chief Executive Officer	Jun 12 '26	Buy	2.50	21,000	52,500	630,812	Jun 16 09:00 AM
Baskies Arnold M	Director	Jan 28 '26	Buy	3.04	10,000	30,400	135,000	Jan 29 08:58 AM
Titterton Lewis H jr	Director	Dec 15 '25	Option Exercise	2.92	16,000	46,720	969,334	Dec 16 08:56 AM
KUMAR AMIT	Chief Executive Officer	Oct 30 '25	Option Exercise	2.92	200,000	584,000	779,925	Oct 31 09:13 AM
Titterton Lewis H jr	Director	Jul 31 '25	Buy	3.08	10,000	30,800	953,334	Aug 04 09:00 AM
KUMAR AMIT	Chief Executive Officer	Jul 30 '25	Buy	3.16	5,000	15,800	579,925	Jul 31 09:00 AM
Baskies Arnold M	Director	Jul 18 '25	Buy	3.39	5,000	16,950	125,000	Jul 21 08:30 AM

DLPN Dolphin Entertainment Inc daily Stock Chart

Peers: ACCS TC TULP WIMI SWAG TJGC FLNT TSQ MCHX NCMI

| Held by: VTI VXF

Index	-
Market Cap	14.58M
Enterprise Value	34.68M
Income	-3.45M
Sales	57.33M
Book/sh	0.58
Cash/sh	0.55
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	271
IPO	Oct 12, 2006

P/E	-
Forward P/E	3.61
PEG	-
P/S	0.25
P/B	1.92
P/C	2.02
P/FCF	-
EV/EBITDA	30.42
EV/Sales	0.60
Quick Ratio	0.73
Current Ratio	0.73
Debt/Eq	3.74
LT Debt/Eq	2.51
Option/Short	Yes / Yes

EPS (ttm)	-0.30
EPS next Y	0.31
EPS next Q	-0.07
EPS this Y	62.96%
EPS next Y	410.00%
EPS next 5Y	-
EPS past 3/5Y	37.82% 25.37%
Sales past 3/5Y	11.86% 18.71%
EPS Y/Y TTM	86.34%
Sales Y/Y TTM	17.92%
EPS Q/Q	-4.65%
Sales Q/Q	5.21%
Earnings	May 12 AMC
EPS/Sales Surpr.	-120.00% -5.85%

Insider Own	28.13%
Insider Trans	2.52%
Inst Own	3.97%
Inst Trans	3.53%
ROA	-6.17%
ROE	-41.53%
ROIC	-13.46%
Gross Margin	17.43%
Oper. Margin	-2.02%
Profit Margin	-6.02%
SMA20	-0.23%
SMA50	-6.54%
SMA200	-24.02%
Trades

Shs Outstand	12.51M
Shs Float	9.36M
Short Float	0.37%
Short Ratio	1.13
Short Interest	0.03M
52W High	1.88 -40.42%
52W Low	0.99 13.13%
Volatility	4.81% 6.26%
ATR (14)	0.07
RSI (14)	46.89
Beta	1.90
Rel Volume	0.00
Avg Volume	30.88K
Volume	0

Perf Week	5.66%
Perf Month	-1.75%
Perf Quarter	-25.33%
Perf Half Y	-32.53%
Perf YTD	-28.21%
Perf Year	-8.20%
Perf 3Y	-70.05%
Perf 5Y	-92.74%
Perf 10Y	-98.88%
Recom	1.00
Target Price	5.00
Prev Close	1.12
Price	1.12
Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-02-21	Reiterated	Maxim Group	Buy	$28
Jan-03-19	Resumed	Maxim Group	Buy	$4.50

Jul-13-26 09:00AM	Dolphin Subsidiary 42West Lands Multiple Nominations for Clients at the 78th Emmy Awards (ACCESSWIRE)
Jul-08-26 09:00AM	Dolphin's 42West Drives High-Profile Anime Expo 2026 Campaigns for Nebula17, TOHO International and GKIDS (ACCESSWIRE)
Jul-01-26 09:00AM	Dolphin Subsidiaries and Clients Have Successful Showing at Cannes Lions Festival of Creativity 2026 (ACCESSWIRE)
Jun-22-26 09:00AM	Dolphin Entertainment and KYNETIC Media Ventures Launch Creator-Led, Audience-First Graviteur Studios (ACCESSWIRE)
Jun-16-26 09:00AM	Dolphin Subsidiary 42West's 25th Tribeca Film Festival Slate Delivered a Standout Film Slate Featuring 16 Film and TV Titles (ACCESSWIRE)
09:25AM	Loading…
Jun-10-26 09:25AM	Dolphin Subsidiary The Digital Dept. Partners With Vidcon To Power Featured Creator Gifting Lounge At Vidcon Anaheim 2026 (ACCESSWIRE)
Jun-02-26 09:00AM	Dolphin Subsidiary The Door and Its DISRPT Division Represents U.S. SailGP Around Major U.S. Race Events (ACCESSWIRE)
May-27-26 09:00AM	Dolphin Celebrates The 2026 Cannes Film Festival with Legacy Talent, High-Profile Premieres, Emerging Filmmakers, And Prestigious Brands (ACCESSWIRE)
May-20-26 09:00AM	Elle Communications Clients Take the Stage at NEXUS Global Summit 2026 (ACCESSWIRE) +5.22%
May-13-26 01:01AM	Dolphin Entertainment Inc (DLPN) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com)
May-12-26 04:26PM	Dolphin Entertainment Reports First Quarter 2026 Results (ACCESSWIRE)
09:00AM	Dolphin Launches Publishing Imprint in Partnership With Copper Books (ACCESSWIRE)
May-11-26 09:00AM	Dolphin to Host First Quarter 2026 Earnings Conference Call on May 12, 2026 (ACCESSWIRE)
May-06-26 09:00AM	Dolphin Subsidiary Clients Shape the Summer 2026 Season With Culture-Defining Festivals and Events (ACCESSWIRE)
Apr-28-26 09:00AM	Shore Fire Client and Afrobeat Pioneer Fela Kuti is the First African Solo Artist to Be Inducted Into The Rock & Roll Hall of Fame (ACCESSWIRE)
09:00AM	Loading…
Apr-21-26 09:00AM	Shore Fire Media's Clients Earn 9 Nominations for Independent Music's Top Awards (ACCESSWIRE)
Apr-17-26 09:00AM	Dolphin Subsidiary 42WEST Drives Global Film Publicity at Cinemacon 2026 (ACCESSWIRE)
Apr-07-26 09:00AM	Dolphin Subsidiaries The Door and Shore Fire Media Partner on Launch of Pawn Shop, a New Sports-Driven Hospitality Concept (ACCESSWIRE)
Mar-31-26 09:00AM	The Door Launches Miami Hub, Expanding Dolphin's South Florida Presence (ACCESSWIRE)
Mar-26-26 08:16PM	Dolphin Entertainment, Inc. Q4 2025 Earnings Call Summary (Moby)
Mar-25-26 11:02PM	Dolphin Entertainment Inc (DLPN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
04:05PM	Dolphin Entertainment Reports Record Fourth Quarter and Full-Year 2025 Results (ACCESSWIRE)
09:00AM	42WEST's 2026 SXSW Festival Slate Delivered Marquee Talent and a Standout Film Slate Featuring a Company-Record 16 World Premiere Titles and Three Audience Award-Winners (ACCESSWIRE)
Mar-23-26 09:00AM	DISRPT Agency, a Division of Dolphin Subsidiary The Door Powers "Art of Glam" During Oscars Week, Driving Cultural Momentum Into Camille Rose's Upcoming Beaute Noir (ACCESSWIRE)
Mar-19-26 04:05PM	Dolphin to Host Fourth Quarter and Year End Earnings Conference Call on March 25, 2026 (ACCESSWIRE)
Mar-17-26 09:00AM	Dolphin Subsidiary 42West Celebrates Oscar Win as "Mr. Nobody Against Putin" Takes Best Documentary Feature at the 98th Academy Awards (ACCESSWIRE)
Mar-10-26 09:00AM	The Digital Dept. Signs Reality TV Show Stars, Top Beauty Creators, And More! (ACCESSWIRE)
Mar-06-26 09:00AM	As Hockey Has a Hollywood Moment, Dolphin's Adaptation of Cult Classic Youngblood Premieres in Los Angeles (ACCESSWIRE)
Mar-03-26 09:00AM	Dolphin CEO Featured on Variety's "Strictly Business" Podcast, Discusses the Creator Economy's Transformation of Marketing and Consumer Product Launches (ACCESSWIRE)
Feb-25-26 09:00AM	Dolphin Expands Miami Footprint to Support Continued Growth Across Subsidiaries (ACCESSWIRE)
09:00AM	Loading…
Feb-18-26 09:00AM	DealMaker and Dolphin Partner to Unlock Community Capital for Celebrity and Influencer Brands (ACCESSWIRE)
Feb-17-26 09:00AM	Dolphin Partners With Vaneast Pictures To Bring Sports Drama Youngblood to Berlin for International Sales (ACCESSWIRE)
Feb-10-26 09:00AM	Dolphin's Powerhouse Subsidiaries Lead Major Brand Activations During Super Bowl LX (ACCESSWIRE)
Feb-03-26 09:00AM	Dolphin Subsidiaries Shore Fire Media and 42West's Clients Present, Perform and Take Home Honors at the 2026 GRAMMY Awards (ACCESSWIRE)
Jan-28-26 09:00AM	Elle Communications Client Harbor Fund Announces Sundance Mountain Resort as New Long-Term Home of Harbor Film Forum (ACCESSWIRE)
Jan-26-26 09:00AM	Dolphin Subsidiary 42West Lands Six Nominations for Clients at the 98th Academy Awards (ACCESSWIRE)
Jan-20-26 09:00AM	Dolphin Subsidiary 42West Brings Exciting and Diverse Projects to the 2026 Sundance Film Festival (ACCESSWIRE)
Jan-13-26 09:00AM	Official Trailer and Key Art Released for Hubert Davis' Adaptation of Hockey Classic "Youngblood" (ACCESSWIRE)
Jan-06-26 09:00AM	Dolphin CEO Issues Letter to Shareholders: Highlights Organic Growth, Financial Strength, AI Leadership, Insider Buying and Positive 2026 Outlook (ACCESSWIRE)
Jan-02-26 09:37AM	Actions Speak Louder: Why This CEO Kept Buying His Own Stock (MarketBeat)
Dec-30-25 09:00AM	Dolphin Subsidiary The Door Provides Strategic Communications Leadership for Hooters as the Iconic Brand Enters a New Era of Ownership and Cultural Relevance (ACCESSWIRE) +11.36%
Dec-23-25 09:00AM	Dolphin Subsidiary Shore Fire Media's Podcast Clients Recognized as 2025's Best (ACCESSWIRE)
Dec-16-25 09:00AM	Dolphin Unveils New 'Dolphin Intelligence' Division to Power AI-Driven Marketing and Communications Strategy and Execution for Partners (ACCESSWIRE)
Dec-10-25 09:00AM	Dolphin Subsidiary 42West Lands Four Nominations for Clients at the 83rd Golden Globe Awards (ACCESSWIRE)
Dec-04-25 09:00AM	Dolphin Partners with Well Go USA for U.S. Distribution of YOUNGBLOOD (ACCESSWIRE)
Nov-19-25 09:00AM	Elle Communications is Agency of Record for FDA-Cleared Neurostimulation Device (ACCESSWIRE)
Nov-13-25 12:01AM	Dolphin Entertainment Inc (DLPN) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Nov-12-25 04:10PM	Dolphin Announces Record Q3 Revenue of $14.8 Million, up 16.7% YoY (ACCESSWIRE)
09:00AM	Dolphin Clients Earn 35 Nominations for the 2026 GRAMMY Awards (ACCESSWIRE)
Nov-11-25 07:37AM	Dolphin Entertainment Inc (DLPN) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-07-25 09:25AM	Dolphin to Host Third Quarter 2025 Earnings Call on November 12 at 4:30 PM ET (ACCESSWIRE) -7.37%
Nov-05-25 09:00AM	Dolphin Subsidiary Elle Communications Launches "The Shift," a Quarterly Report, Weekly Newsletter, and Live Workshop Series on the Future of Communications (ACCESSWIRE)
Oct-28-25 09:00AM	Dolphin (NASDAQ:DLPN) Named One of Crain's Best Places to Work in NYC 2025 (ACCESSWIRE)
Oct-22-25 09:00AM	Dolphin Subsidiary Special Projects Has Another Successful Year Of Talent Relations For The Academy Museum Of Motion Pictures Fifth Annual Gala Honoring Penelope Cruz, Walter Salles, Bruce Springsteen, And Bowen Yang (ACCESSWIRE) -5.13%
Oct-15-25 09:00AM	Dolphin Subsidiary Elle Communications Leads Press For "A Day Of Unreasonable Conversation" Summit At The Getty Center (ACCESSWIRE) -5.03%
Oct-08-25 09:00AM	Dolphin CEO Bill O'Dowd Named to PRNEWS 2025 People of the Year List; Company Recognized on Agency Elite 120 (ACCESSWIRE)
Sep-30-25 09:25AM	Los Angeles Kings Board Feature Film Youngblood (ACCESSWIRE)
Sep-23-25 09:00AM	42WEST, a Subsidiary of Dolphin, Drives Global Reveal of 30 Ninjas' Asteroid - Backed by Google's Android XR and CAA (ACCESSWIRE)
Sep-18-25 09:00AM	BRANDEdit Experience During Fashion Week, Largest To Date, Immerses Top Creators in the Future of Fashion, Beauty, and Wellness (ACCESSWIRE)
Sep-16-25 09:15AM	Dolphin Subsidiary 42West's Clients Score 5 Primetime Emmy Wins (ACCESSWIRE)
Sep-11-25 09:00AM	Dolphin Named to The PR Net 100 (ACCESSWIRE)
Sep-09-25 09:00AM	Dolphin Subsidiary Special Projects Remains a Driving Force at New York Fashion Week, Partnering with CHANEL, FENDI, J.Crew, W Magazine and NYLON (ACCESSWIRE)
Sep-02-25 09:00AM	Dolphin Subsidiary 42West Prepares for the Fall Festival Season with Prolific Client Slate (ACCESSWIRE)
Aug-26-25 09:00AM	Dolphin Subsidiary The Door Expands Hospitality Footprint as Jesse Gerstein Rejoins with Top Tier Hospitality Client Roster (ACCESSWIRE) +6.14%
Aug-21-25 09:00AM	Elle Communications Expands Literary Footprint, Driving Acclaimed Book Launches Across Social Justice, Memoir, and Cultural Commentary (ACCESSWIRE)
Aug-14-25 03:13AM	Dolphin Entertainment Inc (DLPN) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) +7.69%
Aug-13-25 04:20PM	Dolphin Announces Record Q2 Revenue of $14.1 Million, up 23% YoY; Deepens Investment in Women's Sports and Affiliate Marketing (ACCESSWIRE)
09:00AM	Dolphin Forms New Division to Elevate Culinary and Lifestyle Talent (ACCESSWIRE)
Aug-12-25 09:44AM	Earnings To Watch: Dolphin Entertainment Inc (DLPN) Reports Q2 2025 Result (GuruFocus.com)
09:17AM	Youngblood Feature Adaptation Selected to Premiere at the 2025 Toronto International Film Festival (ACCESSWIRE)
Aug-07-25 04:05PM	Dolphin to Host Second Quarter 2025 Earnings Call on August 13 at 4:30 PM ET (ACCESSWIRE)
Aug-05-25 09:00AM	Dolphin Subsidiary Special Projects Secures Talent Lineup For The Fifth Annual Academy Museum Gala (ACCESSWIRE) +5.45%
Jul-28-25 09:00AM	Dolphin Subsidiary 42West Dominates at San Diego Comic-Con (SDCC) 2025 (ACCESSWIRE)
Jul-22-25 09:00AM	Shore Fire Media Named PR Agency of Record for the Miles Davis Estate Ahead of 2026 Centennial (ACCESSWIRE) +9.17%
Jul-16-25 09:00AM	Dolphin Subsidiary 42West's Clients Earn 15 Primetime Emmy Nominations (ACCESSWIRE)
Jul-15-25 05:01PM	William O'Dowd Increases Stake in Dolphin Entertainment, Inc. (DLPN) (Insider Monkey)
Jul-09-25 09:00AM	Dolphin's Consortium of Best-in-Class PR and Marketing Agencies to Represent The Lumistella Company, Global Toy and Entertainment Brand (ACCESSWIRE)
Jul-01-25 09:00AM	DISRPT Agency, a Division of Dolphin Subsidiary The Door, Rolls Out 2025 Client Roster, Reinforcing Its Position at the Forefront of Cultural Influence (ACCESSWIRE)
Jun-24-25 09:25AM	Dolphin Subsidiaries and Clients Have Successful Showing at Cannes Lions Festival of Creativity 2025 (ACCESSWIRE) +5.45%
Jun-17-25 09:00AM	Dolphin Subsidiary 42West Makes Impact at 2025 Tribeca Festival with Exciting Film, TV, and Filmmaker Slate (ACCESSWIRE)
Jun-11-25 09:00AM	Dolphin Subsidiaries Shore Fire Media and The Digital Dept. Take Over CMA Fest 2025 (ACCESSWIRE)
Jun-03-25 09:00AM	Dolphin Subsidiary Special Projects Partners with The Peabody Awards on 2025 Awards Ceremony (ACCESSWIRE)
May-29-25 09:00AM	Dolphin to Present at Maxim Group's 2025 Virtual Tech Conference (ACCESSWIRE)
May-27-25 09:00AM	Shore Fire Media Clients Shape the Summer 2025 Season With Star-Studded Music Festivals and Concert Series (ACCESSWIRE)
May-20-25 09:00AM	Dolphin Subsidiary Special Projects Curates Star-Studded Guest List for the Tory Burch Store Opening on Rodeo Drive (ACCESSWIRE)
May-14-25 03:15AM	Dolphin Entertainment Inc (DLPN) Q1 2025 Earnings Call Highlights: Strategic Growth Amid ... (GuruFocus.com)
May-13-25 04:08PM	Dolphin Reports Q1 2025 Results; Core Entertainment Publicity and Marketing Segment (EPM) Revenue Up 2% YoY to $12.1 Million, Strategic Investments and New Division Launch to Drive Long-Term Growth (ACCESSWIRE)
09:00AM	Dolphin Subsidiary The Digital Dept. Sees Surge In Affiliate Marketing Division, Driving Over $6.6 Million In Gross Retail Sales In First Quarter (ACCESSWIRE)
May-08-25 04:01PM	Dolphin to Host First Quarter 2025 Earnings Call on May 13 at 4:30 PM ET (ACCESSWIRE)
May-07-25 09:00AM	Dolphin Clients Shine at the 2025 Met Gala (ACCESSWIRE)
Apr-29-25 09:00AM	Longtime Shore Fire Media Client Cyndi Lauper To Be Inducted Into Rock & Roll Hall of Fame (ACCESSWIRE)
Apr-22-25 09:00AM	Dolphin Subsidiary the Digital Dept. Hosts Highest-Grossing BRANDEdit Influencer Experience to Date in Los Angeles (ACCESSWIRE)
Apr-15-25 09:00AM	Dolphin CEO Bill O'Dowd Featured on CEO.com Podcast: from Bedroom Startup to Media Powerhouse (ACCESSWIRE)
Apr-10-25 09:00AM	Dolphin Subsidiary Special Projects Springs into the New Season, Partnering with MAX, Warner Bros. and Louis Vuitton (ACCESSWIRE)
Apr-08-25 09:00AM	Dolphin to Present at the LD Micro Investor Conference in New York City on April 10, 2025 at 2:00pm ET (ACCESSWIRE)
Apr-03-25 09:00AM	Dolphin CEO Bill O'Dowd Starts $250,000 10b5-1 Stock Purchase Plan This Week, Building on $100,000 Purchase in 2H 2024; Bullish on Dolphin's Undervalued Shares and Future Growth (ACCESSWIRE)
Mar-28-25 03:21PM	Dolphin Entertainment, Inc. (DLPN) Q4 2024 Earnings Call Transcript (Seeking Alpha)
03:04AM	Dolphin Entertainment Inc (DLPN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Mar-27-25 04:13PM	Dolphin Reports 20% Year-Over-Year Revenue Growth to $51.7 Million and Full-Year Positive Adjusted Operating Income for Fiscal Year 2024 (ACCESSWIRE)
01:20PM	Dolphin Partner Loti AI Expands Digital Identity Protection To Everyone (ACCESSWIRE)

Dolphin Entertainment, Inc. engages in the provision of entertainment marketing and content development. It operates through the following segments: Entertainment Publicity and Marketing, and Content Production. The Entertainment Publicity and Marketing segment consists of 42West, The Door, Elle, Digital Department, Special Projects, and Shore Fire Media. The Content Production segment consists of Dolphin Films and a department within Dolphin which develops, produces, and distributes feature films, television and digital content. The company was founded on March 7, 1995 and is headquartered in Coral Gables, FL.

ChairmanMr. William O'Dowd IV

CFOMs. Mirta A. Negrini

Founder & Chairman of Shore Fire MediMs. Marilyn Laverty

Co-Founder & Co-CEO of The DoorMr. Charles Joseph Dougiello

Co-Founder & Co-CEO of The DoorMs. Lois Najarian O'Neill

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
O'Dowd William IV	Chief Executive Officer	Jul 13 '26	Buy	1.11	4,450	4,953	512,990	Jul 15 09:11 AM
O'Dowd William IV	Chief Executive Officer	Jul 06 '26	Buy	1.16	4,300	4,984	508,540	Jul 07 04:49 PM
O'Dowd William IV	Chief Executive Officer	Jun 29 '26	Buy	1.18	4,200	4,964	504,240	Jun 29 04:36 PM
O'Dowd William IV	Chief Executive Officer	Jun 22 '26	Buy	1.19	4,100	4,858	500,040	Jun 22 06:31 PM
O'Dowd William IV	Chief Executive Officer	Jun 15 '26	Buy	1.21	4,000	4,840	495,940	Jun 15 04:16 PM
O'Dowd William IV	Chief Executive Officer	Jun 08 '26	Buy	1.17	4,100	4,809	491,940	Jun 08 05:44 PM
O'Dowd William IV	Chief Executive Officer	Jun 01 '26	Buy	1.25	3,900	4,867	487,840	Jun 01 03:48 PM
O'Dowd William IV	Chief Executive Officer	May 26 '26	Buy	1.28	3,800	4,860	483,940	May 26 04:04 PM
O'Dowd William IV	Chief Executive Officer	May 18 '26	Buy	1.18	4,100	4,838	480,140	May 20 01:52 PM
O'Dowd William IV	Chief Executive Officer	May 11 '26	Buy	1.46	3,400	4,964	476,040	May 12 08:24 AM
O'Dowd William IV	Chief Executive Officer	May 04 '26	Buy	1.46	3,400	4,964	472,640	May 04 05:02 PM
O'Dowd William IV	Chief Executive Officer	Apr 27 '26	Buy	1.46	3,400	4,950	469,240	Apr 27 04:45 PM
O'Dowd William IV	Chief Executive Officer	Apr 20 '26	Buy	1.52	3,200	4,877	465,840	Apr 20 04:52 PM
O'Dowd William IV	Chief Executive Officer	Apr 13 '26	Buy	1.54	3,200	4,928	462,640	Apr 14 06:12 PM
O'Dowd William IV	Chief Executive Officer	Apr 06 '26	Buy	1.57	3,150	4,946	459,440	Apr 08 02:15 PM
O'Dowd William IV	Chief Executive Officer	Mar 30 '26	Buy	1.57	3,100	4,867	456,290	Apr 01 05:07 PM
O'Dowd William IV	Chief Executive Officer	Mar 23 '26	Buy	1.59	3,100	4,929	453,190	Mar 23 05:26 PM
O'Dowd William IV	Chief Executive Officer	Mar 16 '26	Buy	1.59	3,100	4,929	450,090	Mar 16 07:33 PM
O'Dowd William IV	Chief Executive Officer	Mar 09 '26	Buy	1.67	2,900	4,843	446,990	Mar 09 04:53 PM
O'Dowd William IV	Chief Executive Officer	Mar 02 '26	Buy	1.61	3,100	4,991	444,090	Mar 02 08:15 PM
O'Dowd William IV	Chief Executive Officer	Feb 23 '26	Buy	1.65	3,000	4,950	440,990	Feb 24 07:08 PM
O'Dowd William IV	Chief Executive Officer	Feb 17 '26	Buy	1.47	3,300	4,851	437,990	Feb 17 05:36 PM
O'Dowd William IV	Chief Executive Officer	Feb 09 '26	Buy	1.64	3,000	4,920	434,690	Feb 11 04:38 PM
O'Dowd William IV	Chief Executive Officer	Feb 02 '26	Buy	1.68	2,900	4,872	431,690	Feb 02 05:25 PM
O'Dowd William IV	Chief Executive Officer	Jan 26 '26	Buy	1.80	2,700	4,874	428,790	Jan 27 04:47 PM
O'Dowd William IV	Chief Executive Officer	Jan 20 '26	Buy	1.61	3,100	4,988	426,090	Jan 20 04:00 PM
O'Dowd William IV	Chief Executive Officer	Jan 12 '26	Buy	1.66	3,000	4,980	422,990	Jan 13 04:57 PM
O'Dowd William IV	Chief Executive Officer	Jan 05 '26	Buy	1.62	3,000	4,866	419,990	Jan 05 05:06 PM
O'Dowd William IV	Chief Executive Officer	Dec 29 '25	Buy	1.38	3,600	4,957	416,990	Dec 29 08:36 PM
O'Dowd William IV	Chief Executive Officer	Dec 22 '25	Buy	1.50	3,300	4,957	413,390	Dec 23 04:37 PM
O'Dowd William IV	Chief Executive Officer	Dec 19 '25	Buy	1.54	4,452	6,856	410,090	Dec 22 04:13 PM
O'Dowd William IV	Chief Executive Officer	Dec 15 '25	Buy	1.16	3,000	3,489	405,638	Dec 16 04:30 PM
O'Dowd William IV	Chief Executive Officer	Dec 08 '25	Buy	1.66	3,000	4,971	402,638	Dec 08 04:15 PM
O'Dowd William IV	Chief Executive Officer	Dec 01 '25	Buy	1.67	2,950	4,924	399,638	Dec 01 04:05 PM
O'Dowd William IV	Chief Executive Officer	Nov 10 '25	Buy	1.59	3,100	4,917	396,688	Nov 10 05:05 PM
O'Dowd William IV	Chief Executive Officer	Nov 03 '25	Buy	1.78	2,800	4,973	393,588	Nov 04 04:41 PM
O'Dowd William IV	Chief Executive Officer	Oct 27 '25	Buy	1.64	3,000	4,920	390,788	Oct 28 06:18 PM
O'Dowd William IV	Chief Executive Officer	Oct 20 '25	Buy	1.48	3,300	4,884	387,788	Oct 20 06:03 PM
O'Dowd William IV	Chief Executive Officer	Oct 13 '25	Buy	1.44	3,400	4,896	384,488	Oct 14 08:30 AM
O'Dowd William IV	Chief Executive Officer	Oct 06 '25	Buy	1.55	3,214	4,982	381,088	Oct 06 05:47 PM
O'Dowd William IV	Chief Executive Officer	Sep 29 '25	Buy	1.32	3,700	4,891	377,874	Sep 29 03:53 PM
O'Dowd William IV	Chief Executive Officer	Sep 22 '25	Buy	1.33	3,700	4,921	374,174	Sep 22 04:53 PM
O'Dowd William IV	Chief Executive Officer	Sep 15 '25	Buy	1.22	4,100	4,994	370,474	Sep 15 05:10 PM
O'Dowd William IV	Chief Executive Officer	Sep 08 '25	Buy	1.19	4,150	4,926	366,374	Sep 08 05:54 PM
O'Dowd William IV	Chief Executive Officer	Sep 02 '25	Buy	1.21	4,100	4,977	362,224	Sep 02 04:43 PM
O'Dowd William IV	Chief Executive Officer	Aug 25 '25	Buy	1.13	4,400	4,954	358,124	Aug 27 04:16 PM
O'Dowd William IV	Chief Executive Officer	Aug 21 '25	Buy	1.18	84,745	99,999	353,724	Aug 25 05:10 PM
O'Dowd William IV	Chief Executive Officer	Aug 18 '25	Buy	1.15	4,300	4,924	268,979	Aug 19 04:54 PM
O'Dowd William IV	Chief Executive Officer	Aug 11 '25	Buy	1.13	4,400	4,985	264,679	Aug 13 04:08 PM
O'Dowd William IV	Chief Executive Officer	Aug 04 '25	Buy	1.12	4,400	4,915	260,279	Aug 05 05:11 PM
O'Dowd William IV	Chief Executive Officer	Jul 28 '25	Buy	1.33	3,750	4,976	255,879	Jul 29 04:26 PM
O'Dowd William IV	Chief Executive Officer	Jul 21 '25	Buy	1.19	4,150	4,943	252,129	Jul 21 04:07 PM

BOT

RoboStrategy Inc

COE

51 Talk Online Education Group ADR

TDIC

Dreamland Ltd

IPX

IperionX Ltd ADR

CMC

Commercial Metals Co

PRQR

ProQR Therapeutics N.V

CRDF

Cardiff Oncology Inc

VIRC

Virco Manufacturing Corp

ANIX

Anixa Biosciences Inc

DLPN

Dolphin Entertainment Inc

BOT

COE

TDIC

Dreamland Ltd

IPX

CMC

PRQR

CRDF

VIRC

ANIX

DLPN

Upgrade your Finviz experience